WO2023229237A1 - Electrical nerve therapy system and method using same - Google Patents

Electrical nerve therapy system and method using same Download PDF

Info

Publication number
WO2023229237A1
WO2023229237A1 PCT/KR2023/005535 KR2023005535W WO2023229237A1 WO 2023229237 A1 WO2023229237 A1 WO 2023229237A1 KR 2023005535 W KR2023005535 W KR 2023005535W WO 2023229237 A1 WO2023229237 A1 WO 2023229237A1
Authority
WO
WIPO (PCT)
Prior art keywords
module
charging
electrical
main power
energy harvester
Prior art date
Application number
PCT/KR2023/005535
Other languages
French (fr)
Korean (ko)
Inventor
이윤범
이현웅
Original Assignee
오션스바이오 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오션스바이오 주식회사 filed Critical 오션스바이오 주식회사
Publication of WO2023229237A1 publication Critical patent/WO2023229237A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • A61N1/3787Electrical supply from an external energy source
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1101Detecting tremor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36053Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • A61N1/3785Electrical supply generated by biological activity or substance, e.g. body movement
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R31/00Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
    • G01R31/36Arrangements for testing, measuring or monitoring the electrical condition of accumulators or electric batteries, e.g. capacity or state of charge [SoC]
    • G01R31/371Arrangements for testing, measuring or monitoring the electrical condition of accumulators or electric batteries, e.g. capacity or state of charge [SoC] with remote indication, e.g. on external chargers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R31/00Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
    • G01R31/36Arrangements for testing, measuring or monitoring the electrical condition of accumulators or electric batteries, e.g. capacity or state of charge [SoC]
    • G01R31/382Arrangements for monitoring battery or accumulator variables, e.g. SoC
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02JCIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
    • H02J50/00Circuit arrangements or systems for wireless supply or distribution of electric power
    • H02J50/10Circuit arrangements or systems for wireless supply or distribution of electric power using inductive coupling
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02JCIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
    • H02J7/00Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
    • H02J7/0029Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries with safety or protection devices or circuits
    • H02J7/0036Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries with safety or protection devices or circuits using connection detecting circuits
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02NELECTRIC MACHINES NOT OTHERWISE PROVIDED FOR
    • H02N1/00Electrostatic generators or motors using a solid moving electrostatic charge carrier
    • H02N1/04Friction generators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36067Movement disorders, e.g. tremor or Parkinson disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • A61N1/36096Mood disorders, e.g. depression, anxiety or panic disorder
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02JCIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
    • H02J2207/00Indexing scheme relating to details of circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
    • H02J2207/40Indexing scheme relating to details of circuit arrangements for charging or depolarising batteries or for supplying loads from batteries adapted for charging from various sources, e.g. AC, DC or multivoltage

Definitions

  • the present invention relates to an electrical nerve treatment system and a method using the same.
  • Electronic medicine is a compound word of electronics and pharmaceutical and refers to an electronic device that treats diseases by controlling electrical signals generated in the brain and nerve cells.
  • electromedicine Today, electronic medicines are mainly used to improve disorders or problems that occur in nerves.
  • the principle of electromedicine is the concept of improving or normalizing the pathophysiological environment by stimulating various cells, tissues, and organs, including nerves, with electrical signals generated artificially or through devices designed to be generated in response to body signals.
  • free ions, dipoles, and polarized molecules enable cells, tissues, and organs to generate and conduct electricity.
  • Subtle bioelectricity regulates physiological phenomena and plays an important role in maintaining life.
  • homeostasis and harmony are controlled by electrical and chemical signals, and the electrical and chemical signals interact with each other. Changes in electrical signals can change chemical signals, and chemical signals can change electrical signals.
  • Figure 1 shows that electronic medicine is used to treat rheumatoid arthritis.
  • Rheumatoid arthritis for which no treatment has yet been developed, is known to be a disease caused by an autoimmune reaction. Rheumatoid arthritis occurs when immune cells attack the joints and cause inflammation.
  • Dr. Kevin Tracy of the United States treated a patient with rheumatoid arthritis with electronic medicine. By inserting an electronic medicine into the patient's body and applying electrical signals to the nervous system that controls the spleen, the development of cells that control the immune system, such as T cells, was reduced.
  • Korean Patent No. 10-2284290 which is a registered patent by the present applicant, is disclosed.
  • the prior art relates to 'electronic medicine for treating epilepsy capable of wireless charging and its control method'.
  • the concept of electroweak capable of wireless charging is introduced, and a configuration that prevents electromagnetic interference generated by the wireless charger during the wireless charging process is disclosed.
  • the composition of the prior art is significant in that it solves all the problems associated with using primary batteries at once.
  • Patent Document 1 Korean Patent No. 10-2284290
  • Patent Document 2 Korean Patent Publication No. 10-2017-0046593
  • Patent Document 3 Korean Patent Publication No. 10-2022-0013777
  • the present invention was devised to solve the above-described problems.
  • the present invention provides a system that can appropriately collect bioenergy to enable true self-sufficiency in order to maintain the permanent function of the electropharmaceutical, but also miniaturizes the size.
  • an electrical nerve treatment system which includes an electromedicine that is embedded under the skin and applies preset electrical stimulation to the nerve;
  • a main power module that provides power to the electronic medicine, consisting of a secondary battery capable of repeated charging by receiving power wirelessly from an external wireless charging module; and an energy harvester module configured to generate real-time self-generation using a friction element module, which is electrically connected to the main power module and auxiliary charges the main power module;
  • the main power module includes a first charging mode for auxiliary charging by receiving power from the energy harvester module; and a second charging mode that charges by receiving power wirelessly from an external wireless charging module. It is configured with a charging method that includes, and the first and second charging modes are configured to operate alternatively, but the second charging mode may be set to take precedence over the first charging mode.
  • the main power module is configured to operate in a discharge mode when operating in the first charging mode to apply preset electrical stimulation to the nerve, and when operating in the second charging mode, power is supplied to the electromedicine. It may be operated in a discharging stop mode, where the second charging mode is terminated, and may be operated in a discharging mode that supplies power to the electronic medicine.
  • the electrical capacity of the energy harvester module may be configured to generate 20 to 30% of the power consumed by the main power module.
  • a control module that controls charging and discharging of the main power module and charging by the energy harvester module; It further includes, and the control module is: a. Using the user's body temperature information measured by the body temperature sensing unit, when the body temperature information is greater than a preset standard value; me. Using the temperature information of the main power module measured by the battery temperature sensing unit, when the temperature information is greater than or equal to a preset reference value; and c. Using the current information of the energy harvester module measured by the current sensing unit, when the current information is greater than a preset reference value; If at least one of the above applies, charging by the energy harvester module may be set to stop.
  • control module includes a BMS unit connected to enable communication with the user terminal, and the BMS unit acquires charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module and transmits it to the user terminal. It can be configured to do so.
  • BMS unit connected to enable communication with the user terminal, and the BMS unit acquires charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module and transmits it to the user terminal. It can be configured to do so.
  • SOC State Of Charge
  • the BMS unit detects the electrical connection status of the external wireless charging module and the main power module, and can provide the electrical connection status and real-time charging information to the user terminal.
  • the BMS unit may provide an alarm to the user terminal to induce charging by the energy harvester module when the remaining capacity information of the main power module falls below a preset reference value.
  • control module further includes a vibration sensor unit that detects vibration of the user's body, and when the vibration value sensed through the vibration sensor unit is greater than a preset reference value,
  • the charging can be stopped and the main power module can be controlled to be charged by the energy harvester module.
  • the present invention is a method of using the above-described electrical nerve treatment system, comprising the steps of: (a) applying a preset electrical stimulation from an electronic medicine to the user's nerves and performing a discharge mode of the main power module; (b) a step in which self-power generation is performed by applying vibration to the energy harvester module, in which a first charging mode for charging the main power module is performed; and (c) when the remaining capacity information of the main power module falls below a preset reference value, performing a second charging mode in which power is supplied wirelessly from an external wireless charging module; Provides a method including.
  • the battery when the second charging mode is performed, the battery may be operated in a discharge stop mode in which power supply from the main power module to the electroweak is stopped.
  • the present invention can be equipped with a system that can properly collect bioenergy to enable true self-sufficiency in order to maintain the permanent function of the electromedicine.
  • Figure 1 is a diagram schematically showing the process of performing electrical nerve treatment using electromedicine according to the prior art.
  • Figure 2 is a conceptual diagram of an electrical nerve treatment system according to the first embodiment of the present invention.
  • Figure 3 is a schematic diagram schematically showing the self-generation principle of the energy harvester module of the electrical nerve treatment system of the present invention.
  • Figure 4 is a configuration diagram schematically showing the overall configuration of the electrical nerve treatment system of the present invention.
  • Figure 5 is a conceptual diagram showing the charging method of the main power module of the electrical nerve treatment system of the present invention divided into modes.
  • Figure 6 is a schematic diagram showing the function of the control module of the electrical nerve treatment system of the present invention.
  • Figure 7 is a flowchart of a method of using the electrical nerve treatment system of the present invention.
  • Figure 8 is a conceptual diagram of an electrical nerve treatment system (second embodiment) to which the energy harvester module of the present invention is applied.
  • Figure 9 is a configuration diagram showing the configuration of the energy harvester module of the present invention.
  • Figure 10 is an overall configuration diagram according to a second embodiment of the electrical nerve treatment system.
  • FIG 11 is a schematic diagram of the energy harvester module of the present invention.
  • Figure 12 is a schematic diagram showing a modified example of the energy harvester module of the present invention.
  • Figure 13 is a schematic diagram of an electrical nerve treatment system to which the energy harvester module of the present invention is applied.
  • FIG. 14 shows a cross section of the energy harvester module of FIG. 13.
  • FIG. 15 is a flowchart of a method of using the energy harvester module of the present invention.
  • Figure 16 is a conceptual diagram of an electropharmaceutical monitoring system according to the present invention.
  • Figure 17 is a configuration diagram showing the overall configuration of the electroweak monitoring system according to the present invention.
  • Figure 18 is a schematic diagram schematically explaining the functions of the control module of the present invention.
  • Figure 19 is a schematic diagram schematically showing the process of determining the wireless charging time using the control module of the present invention.
  • Figure 20 is a schematic diagram schematically showing the process by which a user monitors various information about electronic medicine using the control module of the present invention.
  • Figure 21 is a schematic diagram schematically showing the application of the electronic medicine monitoring system of the present invention to electronic prescription.
  • Figure 22 is a block diagram showing the electronic medicine monitoring system server of the present invention.
  • expressions such as “have,” “may have,” “includes,” or “may include” indicate the presence of the corresponding feature (e.g., a numerical value, function, operation, or component such as a part). indicates, does not rule out the presence of additional features.
  • expressions such as “A or B,” “at least one of A or/and B,” or “one or more of A or/and B” may include all possible combinations of the items listed together.
  • first can refer to one element as another element. It is only used to distinguish from an element and does not limit the corresponding components.
  • a first component may be renamed a second component without departing from the scope of rights described herein, and similarly, the second component may also be renamed the first component.
  • the present invention is not limited to the rheumatism treatment illustratively illustrated in FIG. 1. It is stated in advance that it can be applied to all diseases for which electrical neurotherapy can be performed, such as depressive disorder, Parkinson's disease, etc.
  • the electrical nerve treatment system 100 consists of an electromedicine 110, a main power module 120, an energy harvester module 130, and a control module 140. Since it is divided based on the function of the individual components, it can be physically composed into a single, integrated form.
  • the main power module 120 and the energy harvester module 130 of the present invention may be located not only inside the housing dividing the electroweak 110 but also outside the electroweak 110.
  • control module 140 is explained separately in detail.
  • the electrical nerve treatment system 100 applies a secondary battery 122 capable of wireless charging and at the same time applies an energy harvester module 130 capable of real-time self-generation. That is, it is characterized by using the secondary battery 122 and the energy harvester module 130 in a hybrid method.
  • the electromedicine 110 is embedded under the skin and provides electrical stimulation to the nerves.
  • a second channel line 101 is provided on one side of the electroweak 110.
  • the electroweak 110 includes a housing that forms the exterior and an electrical stimulation generator 112.
  • the second channel line 101 is configured to transmit the electrical signal generated by the electrical stimulation generator 112 to the nerve.
  • the electrical stimulation generator 112 may include a printed circuit board (PCB).
  • PCB printed circuit board
  • the material may be at least one of metal such as non-toxic alumina ceramic (Al203) or titanium (Ti), non-toxic acrylic resin, synthetic resin such as nylon, Teflon, polyurethane, polyester, etc., and silicon.
  • the main power module 120 includes a secondary battery 122 and a wireless power receiver 124.
  • a capacity of 325 mAh (nominal 3.6 V) may be applied.
  • Various types of secondary batteries can be applied.
  • the optimal shape can be applied, such as a cylindrical, square, or pouch-shaped battery.
  • a VNS (Vagus Nerve Stimulation) battery can consume 60 to 100 uWh of power in daily life. It is desirable that the secondary battery 122 be designed with a capacity that takes such power usage into consideration.
  • the main power module 120 includes a wireless power receiver 124. It is configured to receive power wirelessly from an external wireless charging module (10). At this time, the wireless charging module 10 may be used while connected to an external power source, but is not limited to this. If the wireless charging module 10 is an energy storage element, it can be configured to wirelessly supply the electric energy stored in the wireless charging module 10 without being connected to an external power source (plug).
  • the wireless power receiver 124 is preferably isolated from other elements by being provided inside a partition-shaped inner shield (not shown).
  • the energy harvester module 130 is configured to generate real-time self-generation using a friction element module.
  • the energy harvester module 130 is a device inserted into the user's body, so when the user moves, a predetermined vibration (or external force) may be applied to the energy harvester module 130.
  • the principle of the energy harvester module 130 is as shown in FIG. 3.
  • the friction element module 132 may refer to the layer assembly form shown in FIG. 3.
  • the friction element module 132 generates non-linear electrical energy using a friction element.
  • This friction element may be a TENG (Triboelectric Nano-Generator).
  • the harvester unit 134 may be configured to sequentially store non-linear electrical energy generated through the friction element module 132 in a multi-stage energy storage (not shown) and supply the stored energy to the energy storage.
  • the energy storage is a different structure from the battery and refers to an energy storage with a small energy storage space that is integrated with the electronic circuit.
  • the surface becomes charged due to frictional charging.
  • the present invention can be performed through multiple layers. Below, for convenience of explanation, an example of double layered will be used, but this is a concept that can be applied to all multi-layers.
  • the energy harvester module 130 is electrically connected to the main power module 120 and is configured to auxiliary charge the main power module 120.
  • the secondary battery 122 of the main power module 120 may be charged in a hybrid manner by the wireless charging module 10 and the energy harvester module 130.
  • the energy harvester module 130 can be configured to generate 20uWh of energy (based on the harvester size of 100mm2), and is designed with a capacity to always compensate for 20 to 30% of the power consumption of the secondary battery 122. It can be. This means that it is designed to have a capacity of about 2% based on the capacity of the secondary battery 122.
  • the main power module 120 mainly receives power from the external wireless charging module 10, and the energy harvester module 130 serves to auxiliary charge the main power module 120.
  • the power supply amount of the energy harvester module 130 is not a relatively large percentage, it is very effective in that it can continuously produce and supply electric energy in response to the user's movements.
  • control of the main power module 120 and the energy harvester module 130 by the control module 140 will be described in detail.
  • the control module 140 controls charging of the main power module 120 and the energy harvester module 130.
  • the 'first charging mode' in which the main power module 120 receives power from the energy harvester module 130 and the main power module 120 receives power from the wireless charging module 10. It is classified into a ‘second charging mode’ that receives .
  • the first and second charging modes are operated alternatively. That is, the main power module 120 may be configured not to be charged simultaneously by the energy harvester module 130 and the wireless charging module 10. Considering charging efficiency and capacity, charging by the wireless charging module 10 can generally receive more power, so the second charging mode can be set to take priority over the first charging mode.
  • the electrical stimulation generator 112 of the electroweak 110 may be in 'discharge mode' while generating an electrical stimulation signal.
  • Discharge mode means that the electrical energy of the main power module 120 or the energy harvester module 130 is consumed.
  • the discharge mode can be performed simultaneously when operating in the first charging mode.
  • the second charging mode it is preferable to operate in a discharging stop mode, and when the second charging mode is terminated (meaning that wireless charging by the wireless charging module 10 is terminated), the discharge is automatically resumed. It can be set to run in mode.
  • the above charging mode operations may be designed to operate simultaneously depending on the designer's selection. That is, this means that even while the second charging mode is operated by the wireless charging module 10, the first charging mode can be operated simultaneously due to the user's movement.
  • a separate mounting means (or fixing means) may be used.
  • the mounting means is configured in the form of a band having a predetermined elasticity, so that the wireless charging module 10 can be maintained in close contact with the body. Accordingly, even when there is movement of the user, the second charging mode can be performed continuously without interruption.
  • the present invention is a system that can safely and stably supply power even when the wireless charging module 10 and the energy harvester module 130 are connected together.
  • control module 140 Detailed functions of the control module 140 will be described with reference to FIGS. 4 and 6.
  • the control module 140 includes a body temperature sensing unit 141, a battery temperature sensing unit 142, a current sensing unit 143, a BMS unit 144, and a vibration sensor unit 145. These are each configured to sense information subject to collection according to a preset cycle or condition.
  • the control module 140 configured to collect vibration information, which is one value. Each of these is configured to have a preset reference value, and when the collected value is greater than or equal to each reference value, the control module 140 instructs the energy harvester module 130 to stop charging. That is, the first charging mode is forcibly stopped.
  • the body temperature information is higher than the standard value, there is a risk of damage to body tissue adjacent to the location where the energy harvester module 130 is installed. This is because it can cause deformation or destruction of body tissues made of protein.
  • the temperature information of the main power module 120 and the current information of the energy harvester module 130 are also for the same reason.
  • the vibration sensor unit 145 is configured to detect vibration (or movement) of the user's body. This is linked to the user's physical activity. For example, when the user is sleeping, the vibration may be relatively low, but when the user is active outdoors, the vibration may be relatively high, and power generation by the energy harvester module 130 may be actively performed.
  • the user may be instructed to stop operating the second charging mode by the wireless charging module 10. This notification may be provided through the user terminal 20.
  • the wireless charging module 10 can be charged while wearing a separate body restraint device for stable charging (second charging mode), and even when the second charging mode is being performed, the user can exercise actively. can do.
  • control module 140 may include a BMS unit 144.
  • the BMS unit 144 may be provided in each of the main power module 120 and the energy harvester module 130, but herein, for convenience of explanation, it is defined that the BMS unit 144 is included in the control module 140. did.
  • the BMS unit 144 monitors the status of the main power module 120 and the energy harvester module 130. In particular, it is configured to obtain charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module 120 and transmit them to the user terminal 20.
  • charge/discharge information and remaining capacity information State Of Charge, SOC
  • the user can check the current status of the main power module 120, predict when wireless charging is needed, the remaining use time of the electronic medicine 110, etc.
  • the BMS unit 144 may be configured to detect the electrical connection status of the external wireless charging module 10 and the main power module 120 and provide the electrical connection status and real-time charging information to the user terminal. This is because, due to the nature of wireless charging, it is necessary to position the wireless power supply unit (not shown) of the wireless charging module 10 and the wireless power receiving unit 124 of the main power module 120 to correspond to each other.
  • the BMS unit 144 may induce charging by the energy harvester module 130 when the remaining capacity information of the main power module 120 falls below a reference value.
  • charging by the energy harvester module 130 is induced by inducing the user's movement. Since the electrical nerve treatment system according to the present invention uses the main power module 120 and the energy harvester module 130 in a hybrid method, the above alarm can be very useful.
  • This method may consist of steps S110 to S130.
  • Step (S110) is a step in which the discharge mode of the main power module 120 is performed while a preset electrical stimulation from the electroweak 110 is applied to the user's nerves.
  • Step S120 is a step in which self-power generation is performed by applying vibration to the energy harvester module 130, and is a step in which a first charging mode for charging the main power module 120 is performed. As the user goes about his or her daily life, vibration is naturally applied to the friction element module 132, thereby producing non-linear electrical energy.
  • the first charging mode can be performed simultaneously with the discharging mode in step S110.
  • step S130 when the remaining capacity information of the main power module 120 falls below a preset reference value, a second charging mode in which power is supplied wirelessly from an external wireless charging module is performed.
  • the second charging mode when the second charging mode is performed, it may be operated in a discharge stop mode in which power supply from the main power module 120 to the electroweak is stopped.
  • the energy harvester module 130 described below may be divided into different embodiments of the electrical nerve treatment system described above.
  • the above-described embodiment was described on the premise that the energy harvester module 200 is located together in the electroweak 110 housing.
  • the energy harvester module 230 is located outside the electroweak 210. It is a structure that is located independently.
  • the energy harvester module 230 may be distinguished from the above-described first embodiment in that it is located outside the electroweak 210. That is, when the lifespan of the energy harvester module 230 expires or replacement is required, only the energy harvester module 230 can be replaced and used separately from the electroweak 210.
  • control module 240 and a main power module 220 are provided inside the electroweak 210 housing.
  • the energy harvester module 230 includes a generator 233, a harvester unit 235, and a case 231.
  • the case 231 forms the exterior of the energy harvester module 230 and protects the internal components. In order to protect the interior from strong external forces, it is preferably made of titanium.
  • a feed-through 236 is formed on one side of the case 231, and a first channel line 237 is formed to extend in the direction of the electroweak 210 through the feed-through 236.
  • the generator 233 generates non-linear electrical energy using the friction element module 232.
  • the principle of generating electric energy using the internal friction element module 232 is as explained in FIG. 3.
  • the friction element module 232 may be any known element capable of generating triboelectricity. Examples of devices applicable to the present invention are as follows. This is a simple example, and is not limited thereto.
  • Hybrid nanogenerator (sliding) by combining triboelectricity and thermoelectricity, through frictional heat for advanced smart sensors;
  • the harvester unit 235 is configured to temporarily store electrical energy provided from the generator 233 in a preset manner.
  • the non-linear electric energy generated through the friction element module 232 of the generator 233 is sequentially stored in the multi-stage multi-energy storage (235a, 235b, 235c), and the energy stored in the multi-energy storage (235a, 235b, 235c) Provides energy.
  • the multi-energy storage 220 is a different configuration from a battery (or battery) and refers to an energy storage with a small energy storage space integrated with an electronic circuit.
  • the harvester unit 235 shown in FIG. 9 is an exemplary structure, and the number of multiple energy storages 235a, 235b, and 235c can be optimally designed according to the designer's selection.
  • the harvester unit 235 is connected to the first channel line 237, and can provide real-time electrical energy to the electroweak 210 through the first channel line 237.
  • the electromagnetic drug 210 is provided with a second channel line 202 that contacts the target nerve (illustratively referred to as the 'vagus nerve' in FIG. 3). Electrical energy provided from the energy harvester module 230 may be provided to the nerves in the user's body through the secondary battery 222 and the second channel line 202.
  • the first channel line 237 may be connected through the connector portion 226. Based on the connector portion 226, the part connected to the electroweak 210 is called a first channel line A (237a), and the part connected to the energy harvester module 230 is called a first channel line B (237b). .
  • the first channel line A (237a) and the first channel line B (237b) are connected to each other through the connector portion 226. In this way, by providing the connector portion 226, the energy harvester module 230 can be easily replaced.
  • Figure 10 shows a modified example of the energy harvester module 230. It shows a configuration in which electrical energy is not only supplied through the first channel line A (237a) and first channel line B (237b), but also a wireless charging method is possible.
  • the energy harvester module 230 may be provided with a wireless power transmission unit 238, and the electroweak 210 may be provided with a wireless power reception unit 224.
  • the wireless power receiver 224 on the electroweak 210 side is preferably used in conjunction with the external wireless charging module 10.
  • wireless charging using the energy harvester module 230 is distinguished in that it is constant charging.
  • charging conditions, methods, and cycles can be set according to the administrator's selection.
  • the secondary battery 222 of the electroweak 210 may be connected to the capacitor unit 226.
  • the capacitor unit 226 may not have a relatively large charging capacity compared to the secondary battery 222. Even though the capacitor unit 226 does not have a very large charge capacity, it can be stably used inside a living body without any structural change because it physically absorbs electrons. In addition, since electrons can be emitted in a very fast time and can be applied to high output, it can be used very effectively as an alternative or auxiliary power source for the electroweak 210.
  • FIG 11 schematically shows a generator 233 equipped with an amplification damper 233c.
  • the amplifying damper 233c is coupled to a pre-calculated position and is formed to sustain the fine movement of the friction element, taking into account the user's movement. As shown in FIG. 11, it can be formed on the outermost layer of the friction element module, and can be formed in plural numbers, with sizes corresponding to regular intervals.
  • the generator 233 to which the amplification damper 233c is attached generates power, and even during movement or at the moment when movement is stopped.
  • the amplification damper 233c can maximize power generation characteristics by continuing the fine movement of the friction element within the spaced apart space.
  • the generator 233 may be composed of multiple layers. This will be explained using the double layer, the most basic of multi-layers, as an example.
  • the multi-layer double layer of FIG. 11 is divided into a first layer 233a and a second layer 233b. Electrical energy is generated by friction when the first and second layers 233a and 233b come into contact.
  • FIG. 12 shows the arrangement of the generator considering the user's movement.
  • the form shown in FIG. 12 takes into account the user's lifestyle pattern, and for people who frequently walk, it is desirable to provide a generator arrangement optimized for walking motion.
  • the applied external force causes friction of the multi-layers 233a and 233b. Encourage it to be used as much as possible.
  • This inclination angle ( ⁇ ) can be calculated based on the user's stride length. This is because in a situation where the user is walking, the user's stride length affects the inclination of the user's body. Since each user's physical condition is different and the stride length is also different, the administrator can set the inclination angle ( ⁇ ) optimized for the user.
  • the area of the multi-layer may be determined by considering the frequency and time of the user's movement. For users who move a lot, the desired charging capacity can be secured even if the area of the multi-layer is relatively small. For users with little movement, the friction area can be increased by forming a large area of the multi-layer.
  • the area of the multi-layer can be achieved by adjusting the length (l) and width (d).
  • the inclination angle ( ⁇ ) and the area of the layer are set to values optimized for the user by securing data on the user's walking characteristics and behavioral characteristics through a smart watch, etc.
  • Figure 13 is a schematic diagram of an electrical nerve treatment system to which the energy harvester module of the present invention is applied. It matches the conceptual diagram shown in FIG. 3.
  • the electroweak 210 is formed so that two channel lines are combined. It consists of a first channel line 237 connected to the energy harvester module 230, and a second channel line 202 connected to the nerve. The tip 202a of the second channel line 202 contacts the nerve area.
  • FIG. 13 shows an exemplary form of the electroweak 210 as well as the energy harvester module 230 according to the present invention, and may be designed in different shapes and sizes.
  • the shape of the energy harvester module 230 may also be circular with respect to a plane.
  • the modified example shown in FIG. 14 is a structure in which directionality is given to the sides that face each other (meaning the sides that rub against each other).
  • a plurality of unit friction elements 239a and 239b are formed on the facing surfaces, respectively.
  • Unit friction elements 239a and 239b formed on each of the upper first layer 233a and second layer 233b have shapes corresponding to each other.
  • the unit friction elements 239a and 239b are formed to have a predetermined slope. This can be viewed as the same concept as the inclination angle ( ⁇ ) described above. Considering the angle of the user's body, the inclination angle of the unit friction elements 239a and 239b is designed.
  • the length (a), number, position, and spacing of the unit friction elements 239a and 239b can be configured in a form optimized for the user according to the designer's selection.
  • the remaining distance (b) between the multi-layer 230' and the case 231 takes into account the hypotenuse length of the unit friction elements 239a and 239b. In other words, it is desirable that the remaining distance (b) is sufficiently formed to not interfere with sliding.
  • the electroweak monitoring system 300 consists of an electroweak 310, a main power module 320, an energy harvester module 330, and a control module 340.
  • the control module 340 checks the status and controls the operation of the electroweak 310, the main power module 320, and the energy harvester module 330.
  • a communication unit 341 capable of wireless communication with the user terminal 20 is provided.
  • the communication unit 341 is wirelessly/wiredly connected to the network and is configured to transmit the obtained information to the user terminal 20.
  • the present invention includes Personal Communication System (PCS), Global System for Mobile communications (GSM), Personal Digital Cellular (PDC), Personal Handyphone System (PHS), Personal Digital Assistant (PDA), and IMT (International Mobile Telecommunication)-2000, CDMA (Code Division Multiple Access)-2000, W-CDMA (W-Code Division Multiple Access), Wibro (Wireless Broadband Internet) terminal, smartphone, smartpad, tablet All types of handheld-based wireless communication devices such as PCs (Tablet PCs) and computing devices such as stationary PCs and laptops can be used, and the above distributed applications are implemented in the form of computer programs and can be read and written. It can be recorded on a possible recording medium and mounted on the terminal.
  • PCs Global System for Mobile communications
  • PDC Personal Digital Cellular
  • PHS Personal Handyphone System
  • IMT International Mobile Telecommunication
  • CDMA Code Division Multiple Access
  • W-CDMA Wide-Code Division Multiple Access
  • Wibro Wireless Broadband Internet
  • the system according to the present invention is based on a network
  • the network refers to a connection structure that allows information exchange between nodes such as terminals and servers.
  • Examples of such networks include the 3rd Generation Partnership Project (3GPP) network, Long Term Evolution (LTE) network, World Interoperability for Microwave Access (WIMAX) network, Internet, Local Area Network (LAN), and Wireless LAN. (Wireless Local Area Network), WAN (Wide Area Network), PAN (Personal Area Network), Bluetooth network, satellite broadcasting network, analog broadcasting network, DMB (Digital Multimedia Broadcasting) network, WiFi, etc. It is not limited.
  • the present invention is characterized by transmitting information obtained through the control module 340 to the user terminal 20.
  • the communication unit 341 may be composed of a transceiver capable of two-way communication.
  • the secondary battery 322 of the main power module 320 may be configured to receive power by being connected to the auxiliary power supply unit 324.
  • the auxiliary power unit 324 includes a capacitor.
  • the auxiliary power unit 324 may be connected to the communication unit 341.
  • the communication unit 341 may be configured with a commercial Bluetooth Low Energy (BLE) board to perform short-distance communication with the user terminal 20.
  • BLE Bluetooth Low Energy
  • control module 340 of the present invention will be described.
  • the control module 340 includes a first status management unit 342, a second status management unit 343, a normal operation determination unit 344, and a wireless charging operation unit 345, which are all connected to the communication unit 341 and interact with each other. It is designed to exchange information.
  • the first state management unit 342 manages the state of the main power module 320 and is configured to obtain and store charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module 320.
  • the state of the main power module 320 is a broad concept meaning all states of the secondary battery 322 included in the main power module 320.
  • the first state management unit 342 may control the main power module 320 to receive power from the auxiliary power unit 324 when the sensed remaining capacity information is below a preset reference value. To this end, it is desirable to design the remaining capacity information of the auxiliary power unit 324 so that it can also be checked in real time by the first status management unit 342.
  • the second status management unit 343 manages the status of the energy harvester module 330 and is configured to obtain and store power information generated by the energy harvester module 330.
  • the energy harvester module 330 performs self-power generation by the user's movement, and the self-power generation performance history is automatically saved. Conversely, the user's movement can be reversely estimated through the second state management unit 343.
  • the normal operation determination unit 344 determines the normal operation of the main power module 320 and the energy harvester module 330. Information about the normal operation of the main power module 320 and the energy harvester module 330 is predefined in the control module 340.
  • the present invention includes an electromagnetic drug that applies electrical signals to the user's nerves, and determining normal operation is a very important function to protect the user's body and prevent accidents.
  • the communication unit 341 and the user terminal 20 are connected in a preset manner using the remaining capacity information of the main power module 320 and the generated power information of the energy harvester module 330. There is a way to determine normal operation by calculating the maximum operating time of wireless communication.
  • the maximum wireless communication operation time between the communication unit 341 and the user terminal 20 is calculated to be a significantly low value. If this happens, it can be judged as ‘abnormal’. This may mean that a lot of power is consumed in other elements other than the main power module 320 and the energy harvester module 330, or it may be a wireless communication error that makes it impossible to transmit and receive accurate information.
  • the control module 340 further includes a wireless charging operation unit 345 that calculates the wireless charging timing of the main power module 320 and provides the wireless charging time to the user terminal 20.
  • the remaining capacity information of the electronic drug 310 of the present invention is the most important information for protecting the user's body. This is because it is directly related to the normal operation of the electronic drug 310.
  • the wireless charging operation unit 345 receives corresponding information from the main power module 320 and the energy harvester module 330, respectively. It is desirable to receive real-time information, but certain cycles and conditions can be set.
  • the wireless charging time of the main power module 320 is determined using the power consumption of the main power module 320, the remaining capacity information of the main power module 320, and the generated power information of the energy harvester module 330.
  • the wireless charging operation unit 345 calculates the ‘first expected use time’ based on the current remaining capacity information of the main power module 320. Afterwards, based on the 'first expected available time', the expected generated power information of the energy harvester module 330 is calculated, and the second expected available time is determined based on this.
  • the secondary expected available time is less than a predetermined value, a re-determination is performed as to whether power saving mode is necessary. It is desirable that the power saving mode is set by the user's selection. This is because it is important for the user to recognize that power saving mode is currently in effect.
  • the first and second state management units 342 and 343 may be configured to store all acquired information in conjunction with time information.
  • the wireless charging operation unit 345 calculates the power consumption amount used for the electrical stimulation applied from the electromagnetic drug 310 and the power information generated by the energy harvester module 330 according to the user's movement based on time in a preset manner. By analyzing, it is possible to determine the wireless charging time of the main power module 320.
  • the control module 410 includes a body temperature sensing unit 340a, a battery temperature sensing unit 340b, a current sensing unit 340c, a tissue temperature sensing unit 340d, a blood flow sensing unit 340e, and a feedback signal sensing unit 340f.
  • the information is provided from .
  • the user's body temperature information measured by the body temperature sensing unit 340a the temperature information of the main power module 320 measured by the battery temperature sensing unit 340b, and the energy measured by the current sensing unit 340c.
  • Current information of the harvester module 330 temperature information of adjacent tissues where the electromedicine 310 is installed measured by the tissue temperature sensing unit 340d, and electromedicine 310 installed measured by the blood flow sensing unit 330e. It is configured to provide blood flow information of adjacent blood vessels to the user terminal 20.
  • control module 340 may be configured to analyze a feedback signal for the electrical signal applied to the electrical stimulation generator 312. Through analysis of these feedback signals, it is possible to check not only whether the nerve is damaged, but also the transmission status of the electrical signal.
  • control module 340 may further include an electrical stimulation setting unit 347.
  • the electrical stimulation setting unit 347 is a component related to electronic prescriptions at medical institutions.
  • the electrical signal of the electroweak 310 may be composed of various elements such as intensity, pattern, and type. This can be named a ‘dataset’. These datasets can only be set up by administrators (experts) with prescribing authority. This is because the act of treating using electronic medicine 310 can be included within the scope of medical practice.
  • Medical treatment and electronic prescriptions can be performed remotely through the user terminal 20.
  • the operation content including the intensity, cycle, and pattern of the electrical stimulation is updated in response to the electronic prescription. That is, a new data set is created, and the electrical stimulation generator 312 is configured to apply an electrical signal according to the contents of the new data set.
  • the present invention provides a configuration for communicating through a user terminal 20 and a server. As described above, it can be performed through an application installed on the user terminal 20.
  • a user interface is provided for each of the main power module 320, the energy harvester module 330, and the electronic drug 310. Users can select any one of these and can check status information for the selected item in real time.
  • charge/discharge information and current remaining capacity information of the main power module 320 obtained from the first status management unit 342 are provided.
  • the generated power information and power generation efficiency information of the energy harvester module 330 obtained from the second state management unit 343 are provided.
  • the electrical stimulation information obtained from the third state management unit 344 is provided in chronological order, and a feedback signal of the electrical stimulation applied to the nerve is provided. In other words, it means providing history information about electrical stimulation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Power Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Charge And Discharge Circuits For Batteries Or The Like (AREA)

Abstract

The present invention relates to an electrical nerve therapy system, comprising: an electroceutical which is buried under the skin and applies a preset electrical stimulation to a nerve; a main power module which provides power to the electroceutical, and comprises a secondary battery capable of being repeatedly charged by wirelessly receiving power from an external wireless charging module; and an energy harvester module configured to perform real-time self-power generation by using a friction element module, wherein the energy harvester module is electrically connected to the main power module to subsidiarily charge the main power module.

Description

전기적 신경치료 시스템 및 이를 이용한 방법Electrical nerve treatment system and method using it
본 발명은 전기적 신경치료 시스템 및 이를 이용한 방법에 관한 기술이다.The present invention relates to an electrical nerve treatment system and a method using the same.
전자약은 전자(electronics)와 약품(pharmaceutical)의 합성어로 뇌와 신경세포에서 발생하는 전기신호를 조절하여 질병을 치료하는 전자장치를 의미한다. Electronic medicine is a compound word of electronics and pharmaceutical and refers to an electronic device that treats diseases by controlling electrical signals generated in the brain and nerve cells.
오늘날 전자약은 주로 신경에서 발생되는 장애나 문제를 개선하기 위하여 사용되고 있다. 전자약의 원리는 인위적으로 또는 신체 신호에 반응하여 생성되도록 설계된 장치를 통해 발생되는 전기 신호로 신경을 포함한 다양한 세포-조직-장기 등을 자극하여 병태 생리환경을 개선 또는 정상화 한다는 개념이다. Today, electronic medicines are mainly used to improve disorders or problems that occur in nerves. The principle of electromedicine is the concept of improving or normalizing the pathophysiological environment by stimulating various cells, tissues, and organs, including nerves, with electrical signals generated artificially or through devices designed to be generated in response to body signals.
체내에서 자유이온들과 쌍극자, 분극 분자들은 세포와 조직, 기관이 전기를 생성하고 전도할 수 있게 한다. 미세한 생체 전기가 생리 현상을 조절하고 생명 유지에 중요한 역할을 한다. 생체에서 항상성 유지와 조화는 전기신호와 화학신호에 의해 조절되며 전기신호와 화학신호는 상호 교류한다. 전기신호의 변화가 화학신호를 변경할 수 있고 화학신호가 전기신호를 변경할 수 있다. In the body, free ions, dipoles, and polarized molecules enable cells, tissues, and organs to generate and conduct electricity. Subtle bioelectricity regulates physiological phenomena and plays an important role in maintaining life. In the living body, homeostasis and harmony are controlled by electrical and chemical signals, and the electrical and chemical signals interact with each other. Changes in electrical signals can change chemical signals, and chemical signals can change electrical signals.
전자약이 개발된 초기에는 심장박동기와 같은 단순한 형태의 이식형 의료기기가 주를 이루었다. 최근에는 뇌전증, 당뇨, 관절염, 고혈압 등 만성 질환을 치료하기 위해 신경조직을 자극하는 전자기기로 진화하고 있다. In the early days of electronic medicine development, simple implantable medical devices such as pacemakers were the mainstay. Recently, electronic devices that stimulate nervous tissue are evolving to treat chronic diseases such as epilepsy, diabetes, arthritis, and high blood pressure.
종래에 사용되는 전통적인 약은 혈관을 타고 돌면서 원하지 않는 부위에서 부작용이 발생할 가능성이 있다. 반면에, 전자약은 치료가 필요한 특정 신경만 선택해 자극하기 때문에 인체에도 안전하다. 전자약은 피하에 매립되어 사용되는 바, 치료가 필요한 특정한 부분만을 골라서 자극하므로 부작용을 최소화 할 수 있고, 만일의 경우 약효를 즉시 중단할 수 있는 장점을 가지고 있다. Traditional medicines used conventionally circulate through the blood vessels and have the potential to cause side effects in unwanted areas. On the other hand, electronic medicine is safe for the human body because it stimulates only the specific nerves that need treatment. Electronic medicine is used by being buried under the skin, so it can minimize side effects by stimulating only the specific area that needs treatment, and has the advantage of being able to immediately stop the drug's effectiveness in case of an emergency.
도 1에는 전자약이 류머티즘 관절염 치료에 사용되는 것을 보여준다. Figure 1 shows that electronic medicine is used to treat rheumatoid arthritis.
아직까지 치료제가 개발되지 않은 류머티즘 관절염은 자가면역반응으로 발생하는 질병으로 알려져 있다. 류머티즘 관절염은 면역세포가 관절을 공격해 염증을 일으키면서 발생한다. 2012년 미국의 케빈트레이시 박사는 전자약으로 류머티즘 관절염 환자를 치료했다. 환자의 몸속에 전자약을 삽입해 비장(脾臟)을 관장하는 신경계에 전기신호를 인가함으로써, T세포 등 면역체계를 관장하는 세포 발생을 줄였다. Rheumatoid arthritis, for which no treatment has yet been developed, is known to be a disease caused by an autoimmune reaction. Rheumatoid arthritis occurs when immune cells attack the joints and cause inflammation. In 2012, Dr. Kevin Tracy of the United States treated a patient with rheumatoid arthritis with electronic medicine. By inserting an electronic medicine into the patient's body and applying electrical signals to the nervous system that controls the spleen, the development of cells that control the immune system, such as T cells, was reduced.
현재 개발된 전자약의 대부분은, 일차전지를 사용하고 있는 수준이다. 일차전지가 모두 방전할 경우, 새로운 일차전지로 교체가 필요한 바, 주기적으로 전지를 인체 외부로 인출하는 것이 강제되는 문제가 있다. Most of the currently developed electronic medicines use primary batteries. When the primary battery is completely discharged, it needs to be replaced with a new primary battery, so there is a problem that the battery is forced to be periodically taken out of the body.
이러한 문제를 해결하기 위한 종래기술로는, 본 출원인에 의한 등록특허인 한국등록특허 제10-2284290호가 개시된다. 상기 종래기술은 '무선충전이 가능한 뇌전증 치료용 전자약 및 이의 제어방법'에 관한 것이다. 무선 충전이 가능한 전자약 개념을 도입하였으며, 무선 충전과정에서 무선 충전기에 의해 발생되는 전자파 교란을 방지하는 구성을 개시한다. 종래기술의 구성은 일차전지를 사용함에 따른 문제를 일거에 해결했다는 점에서 큰 의미가 있다. As a prior art to solve this problem, Korean Patent No. 10-2284290, which is a registered patent by the present applicant, is disclosed. The prior art relates to 'electronic medicine for treating epilepsy capable of wireless charging and its control method'. The concept of electroweak capable of wireless charging is introduced, and a configuration that prevents electromagnetic interference generated by the wireless charger during the wireless charging process is disclosed. The composition of the prior art is significant in that it solves all the problems associated with using primary batteries at once.
이차전지는 반복적인 충방전이 가능하긴 하나, 영속적이라고 볼 수는 없다. Although secondary batteries can be repeatedly charged and discharged, they cannot be considered permanent.
따라서, 전자약의 영속적 기능을 유지하기 위하여 진정한 자체 전원 자급이 가능하도록 생체 에너지를 적절하게 수집할 수 있는 시스템을 갖추되, 크기도 소형화 하여야 하고, 안정성이 유지되는 전자약 개발이 시급한 실정이다. Therefore, in order to maintain the permanent function of electromedicine, it is necessary to have a system that can properly collect bioenergy to enable true self-sufficiency of power, while also miniaturizing the size, and developing electromedicine that maintains stability is urgently needed.
(특허문헌 1) 한국등록특허 제10-2284290호 (Patent Document 1) Korean Patent No. 10-2284290
(특허문헌 2) 한국공개특허 제10-2017-0046593호(Patent Document 2) Korean Patent Publication No. 10-2017-0046593
(특허문헌 3) 한국공개특허 제10-2022-0013777호(Patent Document 3) Korean Patent Publication No. 10-2022-0013777
본 발명은 상기한 문제점을 해결하기 위해 안출된 것으로서, 본 발명은 전자약의 영속적 기능을 유지하기 위하여 진정한 자체 전원 자급이 가능하도록 생체 에너지를 적절하게 수집할 수 있는 시스템을 갖추되, 크기도 소형화 하여야 하고, 안정성이 유지되는 전기적 신경치료 시스템을 제안하고자 한다.The present invention was devised to solve the above-described problems. The present invention provides a system that can appropriately collect bioenergy to enable true self-sufficiency in order to maintain the permanent function of the electropharmaceutical, but also miniaturizes the size. We would like to propose an electrical nerve treatment system that maintains stability.
상기와 같은 과제를 해결하기 위한 본 발명의 일 실시예는, 전기적 신경치료 시스템으로서, 피하에 매립되며, 미리 설정된 전기자극을 신경에 인가하는 전자약; 상기 전자약에 전원을 제공하는 메인전원모듈로서, 외부의 무선충전모듈로부터 무선으로 전원을 공급받아 반복적인 충전이 가능한 이차전지로 구성된, 메인전원모듈; 및 마찰소자모듈을 이용하여 실시간 자가발전을 하도록 구성된 에너지 하베스터모듈로서, 상기 메인전원모듈과 전기적으로 연결되어 상기 메인전원모듈을 보조적으로 충전하는, 에너지 하베스터모듈; 을 포함하는, 전기적 신경치료 시스템을 제공한다. One embodiment of the present invention for solving the above problems is an electrical nerve treatment system, which includes an electromedicine that is embedded under the skin and applies preset electrical stimulation to the nerve; A main power module that provides power to the electronic medicine, consisting of a secondary battery capable of repeated charging by receiving power wirelessly from an external wireless charging module; and an energy harvester module configured to generate real-time self-generation using a friction element module, which is electrically connected to the main power module and auxiliary charges the main power module; Provides an electrical nerve treatment system including.
또한, 상기 메인전원모듈은, 상기 에너지 하베스터모듈로부터 전원을 공급받아 보조적으로 충전하는 제1 충전모드; 및 외부의 무선충전모듈로부터 무선으로 전원을 공급받아 충전하는 제2 충전모드; 를 포함하는 충전방식으로 구성되며, 상기 제1 및 제2 충전모드는, 상호 택일적으로 동작하도록 구성되되, 상기 제2 충전모드가 상기 제1 충전모드에 우선하도록 설정될 수 있다. In addition, the main power module includes a first charging mode for auxiliary charging by receiving power from the energy harvester module; and a second charging mode that charges by receiving power wirelessly from an external wireless charging module. It is configured with a charging method that includes, and the first and second charging modes are configured to operate alternatively, but the second charging mode may be set to take precedence over the first charging mode.
또한, 상기 메인전원모듈은, 상기 제1 충전모드로 동작시에는 방전모드로 동작되어 미리 설정된 전기자극을 신경에 인가하도록 구성되며, 상기 제2 충전모드로 동작시, 상기 전자약으로 전원공급이 중지되는 방전중지모드로 동작되되, 상기 제2 충전모드가 종료되면, 상기 전자약에 전원을 공급하는 방전모드로 동작될 수 있다. In addition, the main power module is configured to operate in a discharge mode when operating in the first charging mode to apply preset electrical stimulation to the nerve, and when operating in the second charging mode, power is supplied to the electromedicine. It may be operated in a discharging stop mode, where the second charging mode is terminated, and may be operated in a discharging mode that supplies power to the electronic medicine.
또한, 상기 에너지 하베스터모듈의 전기적 용량은, 상기 메인전원모듈의 소모 전력량을 기준으로, 20 내지 30%의 전력량을 생성할 수 있는 용량으로 구성될 수 있다. Additionally, the electrical capacity of the energy harvester module may be configured to generate 20 to 30% of the power consumed by the main power module.
또한, 상기 메인전원모듈의 충방전 및 상기 에너지 하베스터모듈에 의한 충전을 제어하는 제어모듈; 을 더 포함하며, 상기 제어모듈은, 가. 체온센싱부에 의해 측정된 사용자의 체온정보를 이용하여, 상기 체온정보가 미리 설정된 기준값 이상일 경우; 나. 전지온도센싱부에 의해 측정된 상기 메인전원모듈의 온도정보를 이용하여, 상기 온도정보가 미리 설정된 기준값 이상일 경우; 및 다. 전류센싱부에 의해 측정된 상기 에너지 하베스터모듈의 전류정보를 이용하여, 상기 전류정보가 미리 설정된 기준값 이상일 경우; 중 적어도 어느 하나에 해당할 경우, 상기 에너지 하베스터모듈에 의한 충전을 중단하도록 설정될 수 있다. Additionally, a control module that controls charging and discharging of the main power module and charging by the energy harvester module; It further includes, and the control module is: a. Using the user's body temperature information measured by the body temperature sensing unit, when the body temperature information is greater than a preset standard value; me. Using the temperature information of the main power module measured by the battery temperature sensing unit, when the temperature information is greater than or equal to a preset reference value; and c. Using the current information of the energy harvester module measured by the current sensing unit, when the current information is greater than a preset reference value; If at least one of the above applies, charging by the energy harvester module may be set to stop.
또한, 상기 제어모듈은, 사용자단말과 통신 가능하도록 연결된 BMS부를 포함하며, 상기 BMS부는, 상기 메인전원모듈의 충방전정보 및 잔존용량정보(State Of Charge, SOC)를 획득하여 상기 사용자단말로 전송하도록 구성될 수 있다. In addition, the control module includes a BMS unit connected to enable communication with the user terminal, and the BMS unit acquires charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module and transmits it to the user terminal. It can be configured to do so.
또한, 상기 BMS부는, 외부의 무선충전모듈 및 상기 메인전원모듈의 전기적 연결상태를 감지하며, 상기 전기적 연결상태와 실시간 충전정보를 사용자단말로 제공할 수 있다. In addition, the BMS unit detects the electrical connection status of the external wireless charging module and the main power module, and can provide the electrical connection status and real-time charging information to the user terminal.
또한, 상기 BMS부는, 상기 메인전원모듈의 잔존용량정보가 미리 설정된 기준값 이하로 떨어지면, 상기 에너지 하베스터모듈에 의한 충전을 유도하는 알람을 사용자단말로 제공할 수 있다. Additionally, the BMS unit may provide an alarm to the user terminal to induce charging by the energy harvester module when the remaining capacity information of the main power module falls below a preset reference value.
또한, 상기 제어모듈은, 사용자 신체의 진동을 감지하는 진동센서부를 더 포함하며, 상기 진동센서부를 통해 센싱된 진동값이 미리 설정된 기준값 이상일 경우, In addition, the control module further includes a vibration sensor unit that detects vibration of the user's body, and when the vibration value sensed through the vibration sensor unit is greater than a preset reference value,
상기 메인전원모듈이 외부의 무선충전모듈에 의해 충전 중인 상태이면, 상기 충전을 중지하고, 상기 에너지 하베스터모듈에 의해 상기 메인전원모듈을 충전하도록 제어할 수 있다. If the main power module is being charged by an external wireless charging module, the charging can be stopped and the main power module can be controlled to be charged by the energy harvester module.
한편, 본 발명은 전술한 전기적 신경치료 시스템을 이용하는 방법으로서, (a) 전자약으로부터 미리 설정된 전기자극이 사용자 신경에 인가되면서 메인전원모듈의 방전모드가 수행되는 단계; (b) 에너지 하베스터모듈에 진동이 인가되어 자가발전이 수행되는 단계로서, 상기 메인전원모듈을 충전시키는 제1 충전모드가 수행되는 단계; 및 (c) 상기 메인전원모듈의 잔존용량정보가 미리 설정된 기준값 이하로 떨어진 경우, 외부의 무선충전모듈로부터 무선으로 전원을 공급받는 제2 충전모드가 수행되는 단계; 를 포함하는, 방법을 제공한다. Meanwhile, the present invention is a method of using the above-described electrical nerve treatment system, comprising the steps of: (a) applying a preset electrical stimulation from an electronic medicine to the user's nerves and performing a discharge mode of the main power module; (b) a step in which self-power generation is performed by applying vibration to the energy harvester module, in which a first charging mode for charging the main power module is performed; and (c) when the remaining capacity information of the main power module falls below a preset reference value, performing a second charging mode in which power is supplied wirelessly from an external wireless charging module; Provides a method including.
또한, 상기 (c) 단계에서, 상기 제2 충전모드가 수행되는 경우, 상기 메인전원모듈로부터 상기 전자약으로 전원공급이 중지되는 방전중지모드로 동작될 수 있다. Additionally, in step (c), when the second charging mode is performed, the battery may be operated in a discharge stop mode in which power supply from the main power module to the electroweak is stopped.
본 발명의 효과는 다음과 같다. The effects of the present invention are as follows.
본 발명은 전자약의 영속적 기능을 유지하기 위하여 진정한 자체 전원 자급이 가능하도록 생체 에너지를 적절하게 수집할 수 있는 시스템을 갖출 수 있다. The present invention can be equipped with a system that can properly collect bioenergy to enable true self-sufficiency in order to maintain the permanent function of the electromedicine.
도 1은 종래기술로써, 전자약을 이용하여 전기적 신경치료를 수행하는 과정을 개략적으로 보여주는 도면이다. Figure 1 is a diagram schematically showing the process of performing electrical nerve treatment using electromedicine according to the prior art.
도 2는 본 발명의 제1 실시예에 따른 전기적 신경치료 시스템의 개념도이다. Figure 2 is a conceptual diagram of an electrical nerve treatment system according to the first embodiment of the present invention.
도 3은 본 발명인 전기적 신경치료 시스템의 에너지 하베스터모듈의 자가발전원리를 개략적으로 도시하는 모식도이다. Figure 3 is a schematic diagram schematically showing the self-generation principle of the energy harvester module of the electrical nerve treatment system of the present invention.
도 4는 본 발명인 전기적 신경치료 시스템의 전체 구성을 개략적으로 나타내는 구성도이다. Figure 4 is a configuration diagram schematically showing the overall configuration of the electrical nerve treatment system of the present invention.
도 5는 본 발명인 전기적 신경치료 시스템의 메인전원모듈의 충전방식을 모드로 구분하여 나타내는 개념도이다. Figure 5 is a conceptual diagram showing the charging method of the main power module of the electrical nerve treatment system of the present invention divided into modes.
도 6은 본 발명인 전기적 신경치료 시스템의 제어모듈의 기능을 나타내는 모식도이다. Figure 6 is a schematic diagram showing the function of the control module of the electrical nerve treatment system of the present invention.
도 7은 본 발명인 전기적 신경치료 시스템을 이용하는 방법의 순서도이다. Figure 7 is a flowchart of a method of using the electrical nerve treatment system of the present invention.
도 8은 본 발명인 에너지 하베스터모듈이 적용된 전기적 신경치료 시스템(제2 실시예)의 개념도이다. Figure 8 is a conceptual diagram of an electrical nerve treatment system (second embodiment) to which the energy harvester module of the present invention is applied.
도 9는 본 발명인 에너지 하베스터모듈의 구성을 나타내는 구성도이다. Figure 9 is a configuration diagram showing the configuration of the energy harvester module of the present invention.
도 10은 전기적 신경치료 시스템의 제2 실시예에 따른 전체 구성도이다. Figure 10 is an overall configuration diagram according to a second embodiment of the electrical nerve treatment system.
도 11은 본 발명인 에너지 하베스터모듈의 개략적인 모식도이다. Figure 11 is a schematic diagram of the energy harvester module of the present invention.
도 12는 본 발명인 에너지 하베스터모듈의 변형예를 도시하는 모식도이다. Figure 12 is a schematic diagram showing a modified example of the energy harvester module of the present invention.
도 13은 본 발명인 에너지 하베스터모듈이 적용된 전기적 신경치료 시스템의 개략적인 모식도이다. Figure 13 is a schematic diagram of an electrical nerve treatment system to which the energy harvester module of the present invention is applied.
도 14는 도 13의 에너지 하베스터모듈의 단면을 도시한다. FIG. 14 shows a cross section of the energy harvester module of FIG. 13.
도 15는 본 발명인 에너지 하베스터모듈을 이용하는 방법의 순서도이다. Figure 15 is a flowchart of a method of using the energy harvester module of the present invention.
도 16은 본 발명에 따른 전자약 모니터링 시스템의 개념도이다. Figure 16 is a conceptual diagram of an electropharmaceutical monitoring system according to the present invention.
도 17는 본 발명에 따른 전자약 모니터링 시스템의 전체적인 구성을 나타내는 구성도이다. Figure 17 is a configuration diagram showing the overall configuration of the electroweak monitoring system according to the present invention.
도 18은 본 발명의 제어모듈에 대한 기능을 개략적으로 설명하는 모식도이다. Figure 18 is a schematic diagram schematically explaining the functions of the control module of the present invention.
도 19는 본 발명의 제어모듈을 이용하여 무선충전시기를 판단하는 과정을 개략적으로 나타내는 모식도이다. Figure 19 is a schematic diagram schematically showing the process of determining the wireless charging time using the control module of the present invention.
도 20은 본 발명의 제어모듈을 이용하여 사용자가 전자약에 대한 다양한 정보를 모니터링하는 과정을 개략적으로 나타내는 모식도이다. Figure 20 is a schematic diagram schematically showing the process by which a user monitors various information about electronic medicine using the control module of the present invention.
도 21은 본 발명인 전자약 모니터링 시스템을 전자처방에 적용하는 것을 개략적으로 나타내는 모식도이다. Figure 21 is a schematic diagram schematically showing the application of the electronic medicine monitoring system of the present invention to electronic prescription.
도 22는 본 발명인 전자약 모니터링 시스템 서버를 나타내는 블록도이다.Figure 22 is a block diagram showing the electronic medicine monitoring system server of the present invention.
이하, 본 발명의 다양한 실시예가 첨부된 도면을 참조하여 기재된다. 본 발명은 특정 실시예에 대해 한정되지 아니며, 본 발명의 실시예들의 다양한 변경(modification), 균등물(equivalent), 및/또는 대체물(alternative)을 포함하는 것으로 이해되어야 한다. 도면의 설명과 관련하여, 유사한 구성요소에 대해서는 유사한 참조 부호가 사용될 수 있다. BRIEF DESCRIPTION OF THE DRAWINGS Various embodiments of the present invention are described below with reference to the accompanying drawings. It should be understood that the present invention is not limited to specific embodiments, but includes various modifications, equivalents, and/or alternatives to the embodiments of the present invention. In connection with the description of the drawings, similar reference numbers may be used for similar components.
본원에서, "가진다", "가질 수 있다", "포함한다", 또는 "포함할 수 있다" 등의 표현은 해당 특징(예: 수치, 기능, 동작, 또는 부품 등의 구성요소)의 존재를 가리키며, 추가적인 특징의 존재를 배제하지 않는다. As used herein, expressions such as “have,” “may have,” “includes,” or “may include” indicate the presence of the corresponding feature (e.g., a numerical value, function, operation, or component such as a part). indicates, does not rule out the presence of additional features.
본원에서, "A 또는 B", "A 또는/및 B 중 적어도 하나", 또는 "A 또는/및 B 중 하나 또는 그 이상" 등의 표현은 함께 나열된 항목들의 모든 가능한 조합을 포함할 수 있다. 예를 들면, "A 또는 B", "A 및 B 중 적어도 하나", 또는 "A 또는 B 중 적어도 하나"는, (1) 적어도 하나의 A를 포함, (2) 적어도 하나의 B를 포함, 또는 (3) 적어도 하나의 A 및 적어도 하나의 B 모두를 포함하는 경우를 모두 지칭할 수 있다. As used herein, expressions such as “A or B,” “at least one of A or/and B,” or “one or more of A or/and B” may include all possible combinations of the items listed together. For example, “A or B”, “at least one of A and B”, or “at least one of A or B” (1) includes at least one A, (2) includes at least one B, or (3) it may refer to all cases including both at least one A and at least one B.
본원에서 사용된 "제1", "제2", "첫째", 또는 "둘째" 등의 표현들은 다양한 구성요소들을, 순서 및/또는 중요도에 상관없이 수식할 수 있고, 한 구성요소를 다른 구성요소와 구분하기 위해 사용될 뿐 해당 구성요소들을 한정하지 않는다. 예를 들면, 본원에 기재된 권리 범위를 벗어나지 않으면서 제1 구성요소는 제2 구성요소로 명명될 수 있고, 유사하게 제2 구성요소도 제1 구성요소로 바꾸어 명명될 수 있다. As used herein, expressions such as “first,” “second,” “first,” or “second” can describe various elements, regardless of order and/or importance, and can refer to one element as another element. It is only used to distinguish from an element and does not limit the corresponding components. For example, a first component may be renamed a second component without departing from the scope of rights described herein, and similarly, the second component may also be renamed the first component.
본원에서 사용된 용어들은 단지 특정한 실시예를 설명하기 위해 사용된 것으로, 다른 실시예의 범위를 한정하려는 의도가 아닐 수 있다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함할 수 있다. 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 용어들은 본원에 기재된 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가질 수 있다. Terms used herein are merely used to describe specific embodiments and may not be intended to limit the scope of other embodiments. Singular expressions may include plural expressions, unless the context clearly indicates otherwise. Terms used herein, including technical or scientific terms, may have the same meaning as commonly understood by a person of ordinary skill in the technical fields described herein.
본원에 사용된 용어들 중 일반적인 사전에 정의된 용어들은 관련 기술의 문맥상 가지는 의미와 동일 또는 유사한 의미로 해석될 수 있으며, 본원에서 명백하게 정의되지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다. 경우에 따라서, 본원에서 정의된 용어일지라도 본원의 실시예들을 배제하도록 해석될 수 없다. Among the terms used herein, terms defined in general dictionaries may be interpreted to have the same or similar meaning as the meaning they have in the context of related technology, and unless clearly defined herein, shall not be interpreted in an ideal or excessively formal sense. No. In some cases, even terms defined herein cannot be interpreted to exclude embodiments herein.
이하 첨부된 도면 및 실시예를 통하여 본 발명을 상세히 설명하기로 하며, 하기에서 본 발명을 설명함에 있어 관련된 공지 기능 또는 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우에는 그에 대해 상세한 설명을 생략하였다. The present invention will be described in detail below through the accompanying drawings and examples. In the following description of the present invention, if it is judged that a detailed description of related known functions or configurations may unnecessarily obscure the gist of the present invention, A detailed description thereof has been omitted.
그리고 후술되는 용어들은 본 발명에서의 기능을 고려하여 정의된 용어들로써, 이는 사용자, 운용자의 의도 또는 관례 등에 따라 달라질 수 있다. 그러므로 그 정의는 본 명세서 전반에 걸친 내용을 토대로 내려져야 할 것이다. The terms described below are defined in consideration of the functions in the present invention, and may vary depending on the intention or custom of the user or operator. Therefore, the definition should be made based on the contents throughout this specification.
본 발명은 도 1에서 예시적으로 설명된 류머티즘 치료에 제한되는 것은 아니다. 우울장애(depressive disorder), 파킨슨병(Parkinson's) 등과 같이, 전기적 신경치료를 수행할 수 있는 모든 질병에 적용될 수 있음을 미리 명시하는 바이다. The present invention is not limited to the rheumatism treatment illustratively illustrated in FIG. 1. It is stated in advance that it can be applied to all diseases for which electrical neurotherapy can be performed, such as depressive disorder, Parkinson's disease, etc.
에너지 하베스터모듈이 구비된 전기적 신경치료 시스템Electrical nerve treatment system equipped with energy harvester module
이하에서는 도 2 내지 7을 참조하여, 전기적 신경치료 시스템(100)을 설명한다. Below, with reference to FIGS. 2 to 7, the electrical nerve treatment system 100 will be described.
본 발명에 따른 전기적 신경치료 시스템(100)은 전자약(110), 메인전원모듈(120), 에너지 하베스터모듈(130) 및 제어모듈(140)로 구성된다. 개별 구성들의 기능을 중심으로 구분한 것인 바, 물리적으로는 통합된 단일의 형태로 구성될 수 있다. The electrical nerve treatment system 100 according to the present invention consists of an electromedicine 110, a main power module 120, an energy harvester module 130, and a control module 140. Since it is divided based on the function of the individual components, it can be physically composed into a single, integrated form.
다시 말해, 본 발명의 메인전원모듈(120) 및 에너지 하베스터모듈(130)은 전자약(110)을 구획하는 하우징 내부 뿐만 아니라, 전자약(110) 외측에 위치될 수도 있다. In other words, the main power module 120 and the energy harvester module 130 of the present invention may be located not only inside the housing dividing the electroweak 110 but also outside the electroweak 110.
본원에서는 이해의 편의를 위해, 구성을 구분하여 설명하며, 제어모듈(140)에 대해서는 별도로 자세히 설명한다. In this document, for convenience of understanding, the configurations are explained separately, and the control module 140 is explained separately in detail.
본 발명에 따른 전기적 신경치료 시스템(100)은, 무선충전이 가능한 이차전지(122)를 적용함과 동시에, 실시간 자가발전이 가능한 에너지 하베스터모듈(130)을 적용한 것이다. 즉, 이차전지(122) 및 에너지 하베스터모듈(130)을 하이브리드 방식으로 사용하는 것을 특징으로 한다. The electrical nerve treatment system 100 according to the present invention applies a secondary battery 122 capable of wireless charging and at the same time applies an energy harvester module 130 capable of real-time self-generation. That is, it is characterized by using the secondary battery 122 and the energy harvester module 130 in a hybrid method.
전자약(110)은 피하에 매립되어 신경에 전기자극을 제공하는 구성이다. 이를 위해, 전자약(110)의 일측에는 제2 채널라인(101)이 구비된다. 전자약(110)은 외관을 형성하는 하우징 및 전기자극발생부(112)를 포함한다. 제2 채널라인(101)은 전기자극발생부(112)에서 발생된 전기신호를 신경에 전달하도록 구성된다. The electromedicine 110 is embedded under the skin and provides electrical stimulation to the nerves. For this purpose, a second channel line 101 is provided on one side of the electroweak 110. The electroweak 110 includes a housing that forms the exterior and an electrical stimulation generator 112. The second channel line 101 is configured to transmit the electrical signal generated by the electrical stimulation generator 112 to the nerve.
전기자극발생부(112)는 PCB(Printed Circuit Board)를 포함할 수 있다. 또한, 무선충전모듈(10)에 의한 충전시 PCB가 교란될 수 있는 바, 전자파를 차폐하는 구조 및 소재가 적용될 수 있다. 상기 소재는 무독성의 알루미나세라믹(Al203) 또는 티타늄(Ti)과 같은 금속, 무독성 아크릴 수지, 나일론, 테플론, 폴리우레탄, 폴리에스테르 등과 같은 합성수지, 실리콘 중 적어도 어느 하나일 수 있다. The electrical stimulation generator 112 may include a printed circuit board (PCB). In addition, since the PCB may be disturbed when charging by the wireless charging module 10, a structure and material that shields electromagnetic waves may be applied. The material may be at least one of metal such as non-toxic alumina ceramic (Al203) or titanium (Ti), non-toxic acrylic resin, synthetic resin such as nylon, Teflon, polyurethane, polyester, etc., and silicon.
메인전원모듈(120)은 이차전지(122) 및 무선전력수신부(124)를 포함한다. 이차전지(122)의 일 예시로는, 325mAh(nominal 3.6V)의 용량이 적용될 수 있다. 다양한 형태의 이차전지가 적용될 수 있다. 원통형, 각형, 파우치형 전지 등 설계자의 선택에 따라, 최적의 형태가 적용될 수 있다. The main power module 120 includes a secondary battery 122 and a wireless power receiver 124. As an example of the secondary battery 122, a capacity of 325 mAh (nominal 3.6 V) may be applied. Various types of secondary batteries can be applied. Depending on the designer's choice, the optimal shape can be applied, such as a cylindrical, square, or pouch-shaped battery.
일 예시로써, VNS(Vagus Nerve Stimulation, 미주신경자극) 배터리는 일상 생활에서 60 내지 100uWh의 전력을 소모할 수 있다. 이차전지(122)는 이러한 전력사용량을 고려한 용량으로 설계되는 것이 바람직하다. As an example, a VNS (Vagus Nerve Stimulation) battery can consume 60 to 100 uWh of power in daily life. It is desirable that the secondary battery 122 be designed with a capacity that takes such power usage into consideration.
메인전원모듈(120)은 무선전력수신부(124)를 포함한다. 외부의 무선충전모듈(10)로부터 무선으로 전원을 공급받도록 구성된다. 이 때, 무선충전모듈(10)은 외부의 전원에 연결된 상태에서 사용될 수도 있으나, 꼭 이에 제한되는 것은 아니다. 무선충전모듈(10)이 에너지 저장소자일 경우, 외부의 전원(플러그)에 연결됨 없이, 무선충전모듈(10)이 저장하는 전기에너지를 무선으로 공급하도록 구성될 수 있다. The main power module 120 includes a wireless power receiver 124. It is configured to receive power wirelessly from an external wireless charging module (10). At this time, the wireless charging module 10 may be used while connected to an external power source, but is not limited to this. If the wireless charging module 10 is an energy storage element, it can be configured to wirelessly supply the electric energy stored in the wireless charging module 10 without being connected to an external power source (plug).
전자약(110) 하우징 내부에서, 무선전력수신부(124)는 격벽형태의 이너쉴드(미도시) 내측에 구비됨으로써, 다른 소자들과 격리되는 것이 바람직하다. Inside the electroweak 110 housing, the wireless power receiver 124 is preferably isolated from other elements by being provided inside a partition-shaped inner shield (not shown).
에너지 하베스터모듈(130)은 마찰소자모듈을 이용하여 실시간 자가발전을 하도록 구성된다. 에너지 하베스터모듈(130)은 사용자의 체내에 삽입되는 소자인 바, 사용자의 움직임이 발생할 경우, 에너지 하베스터모듈(130)에도 소정의 진동(또는 외력)이 인가될 수 있다. The energy harvester module 130 is configured to generate real-time self-generation using a friction element module. The energy harvester module 130 is a device inserted into the user's body, so when the user moves, a predetermined vibration (or external force) may be applied to the energy harvester module 130.
에너지 하베스터모듈(130)의 원리는 도 3에 도시된 바와 같다. The principle of the energy harvester module 130 is as shown in FIG. 3.
마찰소자모듈(132)은 도 3의 도시된 레이어 어셈블리 형태를 의미할 수 있다. 마찰소자모듈(132)은 마찰소자를 이용하여 비선형적 전기 에너지를 발전시킨다. 이러한 마찰소자는 TENG(Triboelectric Nano-Generator)일 수 있다. The friction element module 132 may refer to the layer assembly form shown in FIG. 3. The friction element module 132 generates non-linear electrical energy using a friction element. This friction element may be a TENG (Triboelectric Nano-Generator).
하베스터부(134)는 마찰소자모듈(132)을 통해 발전된 비선형적 전기 에너지를 다단계로 구성된 에너지 저장소(미도시)에 순차적으로 저장시키고, 에너지 저장소에 저장된 에너지를 공급하도록 구성될 수 있다. 이 때, 에너지 저장소는 배터리와는 상이한 구성으로서, 전자회로와 일체로 구성된 에너지 저장 공간이 작은 에너지 저장소를 의미한다. The harvester unit 134 may be configured to sequentially store non-linear electrical energy generated through the friction element module 132 in a multi-stage energy storage (not shown) and supply the stored energy to the energy storage. At this time, the energy storage is a different structure from the battery and refers to an energy storage with a small energy storage space that is integrated with the electronic circuit.
도 3을 참조하면, 서로 다른 레이어가 접촉하면(contact) 마찰 대전에 의해 표면이 대전되는 현상이 나타난다. 본 발명은 멀티 레이어를 통해 수행될 수 있다. 이하에서는, 설명의 편의를 위해, 두 레이어(double layered)의 예시를 들어 설명하나, 이는 멀티 레이어에 모두 적용될 수 있는 개념이다. Referring to FIG. 3, when different layers come into contact, the surface becomes charged due to frictional charging. The present invention can be performed through multiple layers. Below, for convenience of explanation, an example of double layered will be used, but this is a concept that can be applied to all multi-layers.
구체적으로, 두 레이어가 분리되면(separation) 정전기 유도 현상에 의해 위·아래 전극에 보상 전하가 축적되고, 이에 따라 전하 균형이 맞을 때까지 외부 전극을 통해 전류가 흐르게 된다. 두 물질이 다시 가까워지면 축적되었던 보상 전하가 사라짐으로써 처음과는 반대 방향의 전류가 외부 전극을 통해 흐르게 되며, 반복되는 접촉 및 분리과정을 통해 양 전극 간에 지속적으로 교류 전류(Alternating Current)가 흐르게 되는 원리이다. Specifically, when the two layers are separated, compensating charges are accumulated on the upper and lower electrodes due to electrostatic induction, and thus current flows through the external electrodes until the charge balance is achieved. When the two materials become closer again, the accumulated compensation charge disappears, causing a current in the opposite direction to the first to flow through the external electrode, and through repeated contact and separation processes, an alternating current continues to flow between the two electrodes. It is a principle.
에너지 하베스터모듈(130)은 메인전원모듈(120)과 전기적으로 연결되며, 메인전원모듈(120)을 보조적으로 충전하도록 구성된다. 메인전원모듈(120)의 이차전지(122)는 무선충전모듈(10) 및 에너지 하베스터모듈(130)에 의해 하이브리드 방식으로 충전 가능할 수 있다. The energy harvester module 130 is electrically connected to the main power module 120 and is configured to auxiliary charge the main power module 120. The secondary battery 122 of the main power module 120 may be charged in a hybrid manner by the wireless charging module 10 and the energy harvester module 130.
일 예시로써, 에너지 하베스터모듈(130)은 20uWh의 에너지를 생성하도록 구성될 수 있고(하베스터 크기 100mm2 기준), 이차전지(122)의 소모전력의 20 내지 30%를 상시 보상할 수 있는 용량으로 설계될 수 있다. 이는 이차전지(122)의 용량을 기준으로, 약 2% 정도의 용량으로 설계되는 것을 의미한다. As an example, the energy harvester module 130 can be configured to generate 20uWh of energy (based on the harvester size of 100mm2), and is designed with a capacity to always compensate for 20 to 30% of the power consumption of the secondary battery 122. It can be. This means that it is designed to have a capacity of about 2% based on the capacity of the secondary battery 122.
메인전원모듈(120)은 외부의 무선충전모듈(10)로부터 주로 전력을 공급받는 바, 에너지 하베스터모듈(130)은 메인전원모듈(120)을 보조적으로 충전하는 역할을 수행한다. 에너지 하베스터모듈(130)의 전력공급량은 상대적으로 그리 큰 비율은 아니지만, 사용자의 움직임에 대응하여 지속적으로 전기에너지를 생산하여 공급할 수 있다는 점에서 큰 효과가 있다. The main power module 120 mainly receives power from the external wireless charging module 10, and the energy harvester module 130 serves to auxiliary charge the main power module 120. Although the power supply amount of the energy harvester module 130 is not a relatively large percentage, it is very effective in that it can continuously produce and supply electric energy in response to the user's movements.
이하에서는, 도 4 내지 7을 참조하여, 제어모듈(140)에 의한 메인전원모듈(120) 및 에너지 하베스터모듈(130)의 제어를 상세히 설명한다. Below, with reference to FIGS. 4 to 7, control of the main power module 120 and the energy harvester module 130 by the control module 140 will be described in detail.
제어모듈(140)은 메인전원모듈(120) 및 에너지 하베스터모듈(130)의 충전을 제어한다. The control module 140 controls charging of the main power module 120 and the energy harvester module 130.
도 5를 먼저 참조하여 설명한다. 메인전원모듈(120)을 기준으로, 메인전원모듈(120)이 에너지 하베스터모듈(130)로부터 전력을 공급받는 '제1 충전모드' 및 메인전원모듈(120)이 무선충전모듈(10)로부터 전력을 공급받는 '제2 충전모드'로 구분된다. The description will first be made with reference to FIG. 5 . Based on the main power module 120, the 'first charging mode' in which the main power module 120 receives power from the energy harvester module 130 and the main power module 120 receives power from the wireless charging module 10. It is classified into a ‘second charging mode’ that receives .
여기서, 제1 및 제2 충전모드는 상호 택일적으로 동작되는 것이 바람직하다. 즉, 메인전원모듈(120)은 에너지 하베스터모듈(130) 및 무선충전모듈(10)에 의해 동시에 충전되지 않도록 구성될 수 있다. 충전 효율 및 용량을 고려할 때, 무선충전모듈(10)에 의한 충전이 일반적으로 더 많은 전력을 공급받을 수 있는 바, 제2 충전모드가 제1 충전모드에 우선하는 것으로 설정될 수 있다. Here, it is preferable that the first and second charging modes are operated alternatively. That is, the main power module 120 may be configured not to be charged simultaneously by the energy harvester module 130 and the wireless charging module 10. Considering charging efficiency and capacity, charging by the wireless charging module 10 can generally receive more power, so the second charging mode can be set to take priority over the first charging mode.
전자약(110)의 전기자극발생부(112)는 전기자극신호를 발생하면서, '방전모드'가 수행될 수 있다. 방전모드는 메인전원모듈(120) 또는 에너지 하베스터모듈(130)의 전기에너지가 소모되는 것을 의미한다. The electrical stimulation generator 112 of the electroweak 110 may be in 'discharge mode' while generating an electrical stimulation signal. Discharge mode means that the electrical energy of the main power module 120 or the energy harvester module 130 is consumed.
에너지 하베스터모듈(130)은 상시 충전 가능하도록 구성되는 것이 효율적인 바, 제1 충전모드 동작시에는 방전모드도 동시에 수행 가능하도록 설정되는 것이 바람직하다. 반면에, 제2 충전모드 동작시에는 방전중지모드로 동작되는 것이 바람직하며, 제2 충전모드가 종료되면(무선충전모듈(10)에 의한 무선충전이 종료되는 것을 의미함), 다시 자동으로 방전모드로 수행되도록 설정될 수 있다. Since it is efficient to configure the energy harvester module 130 to be capable of charging at all times, it is preferable to set it so that the discharge mode can be performed simultaneously when operating in the first charging mode. On the other hand, when operating the second charging mode, it is preferable to operate in a discharging stop mode, and when the second charging mode is terminated (meaning that wireless charging by the wireless charging module 10 is terminated), the discharge is automatically resumed. It can be set to run in mode.
이는 안정적인 무선충전 및 전기자극발생부(112)로부터 전기자극신호의 발생에 전기적 간섭 현상이 발생되는 것을 방지하기 위함이다. 전기자극발생부(112)와 연결된 제2 채널라인(114)은 체내의 신경과 직접 접촉되어 연결되는 바, 미세한 전기적 간섭이 발생되는 경우에도, 사용자에게 악영향을 줄 수 있기 때문이다. This is to prevent electrical interference from occurring in the stable wireless charging and generation of the electrical stimulation signal from the electrical stimulation generator 112. This is because the second channel line 114 connected to the electrical stimulation generator 112 is directly connected to the nerves in the body, and even if minute electrical interference occurs, it may have a negative impact on the user.
다만, 상기의 충전모드 동작은 설계자의 선택에 따라, 동시에 동작되도록 설계될 수 있다. 즉, 무선충전모듈(10)에 의한 제2 충전모드가 동작되는 중에도, 사용자의 움직임에 의해, 제1 충전모드가 동시에 동작될 수 있음을 의미한다. 이 경우에는, 무선충전모듈(10)에 의한 안정적인 충전을 유지하기 위해, 별도의 거치수단(또는 고정수단)이 사용될 수 있다. 거치수단은 소정의 탄성을 갖는 밴드형태로 구성됨으로써, 무선충전모듈(10)의 신체 밀착을 유지할 수 있다. 이에 따라, 사용자의 움직임이 있는 경우에도, 제2 충전모드가 끊김없이 연속적으로 수행될 수 있다. However, the above charging mode operations may be designed to operate simultaneously depending on the designer's selection. That is, this means that even while the second charging mode is operated by the wireless charging module 10, the first charging mode can be operated simultaneously due to the user's movement. In this case, in order to maintain stable charging by the wireless charging module 10, a separate mounting means (or fixing means) may be used. The mounting means is configured in the form of a band having a predetermined elasticity, so that the wireless charging module 10 can be maintained in close contact with the body. Accordingly, even when there is movement of the user, the second charging mode can be performed continuously without interruption.
즉, 본 발명은 무선충전모듈(10)과 에너지 하베스터모듈(130)이 함께 연결되더라도, 안전하고 안정적으로 전력을 공급할 수 있는 시스템이다. In other words, the present invention is a system that can safely and stably supply power even when the wireless charging module 10 and the energy harvester module 130 are connected together.
도 4 및 6을 참조하여 제어모듈(140)의 세부 기능을 설명한다. Detailed functions of the control module 140 will be described with reference to FIGS. 4 and 6.
제어모듈(140)은 체온센싱부(141), 전지온도센싱부(142), 전류센싱부(143), BMS부(144) 및 진동센서부(145)를 포함한다. 이들은 각각 미리 설정된 주기 또는 조건에 의해 수집의 대상이 되는 정보를 센싱하도록 구성된다. The control module 140 includes a body temperature sensing unit 141, a battery temperature sensing unit 142, a current sensing unit 143, a BMS unit 144, and a vibration sensor unit 145. These are each configured to sense information subject to collection according to a preset cycle or condition.
즉, 제어모듈(140)에 의해, 사용자의 체온정보, 메인전원모듈(120)(바람직하게는 이차전지(122))의 온도정보, 에너지 하베스터모듈(130)의 전류정보, 사용자의 움직임을 정량화한 값인 진동정보 등을 수집하도록 구성된다. 이들 각각은 미리 설정된 기준값을 갖도록 구성되며, 제어모듈(140)은 수집된 값이 각각의 기준값 이상일 경우, 에너지 하베스터모듈(130)의 충전 동작을 중지하도록 지시한다. 즉, 제1 충전모드가 강제 중지되는 것이다. That is, the user's body temperature information, temperature information of the main power module 120 (preferably the secondary battery 122), current information of the energy harvester module 130, and user's movement are quantified by the control module 140. It is configured to collect vibration information, which is one value. Each of these is configured to have a preset reference value, and when the collected value is greater than or equal to each reference value, the control module 140 instructs the energy harvester module 130 to stop charging. That is, the first charging mode is forcibly stopped.
상기의 기준값을 초과하는 경우, 에너지 하베스터모듈(130)의 에러 또는 고장일 가능성이 있는 바, 사용자의 신체를 보호하기 위해, 강제 중지시키는 것이다. If the above reference value is exceeded, there is a possibility of an error or malfunction of the energy harvester module 130, and the energy harvester module 130 is forced to stop to protect the user's body.
가령, 체온정보가 기준값 이상일 경우, 에너지 하베스터모듈(130)이 설치된 위치와 인접한 체내 조직이 손상될 위험이 있다. 단백질로 구성된 체내 조직의 변형이나 파괴를 야기시킬 수 있기 때문이다. 메인전원모듈(120)의 온도정보와 에너지 하베스터모듈(130)의 전류정보 역시 마찬가지의 이유이다. For example, if the body temperature information is higher than the standard value, there is a risk of damage to body tissue adjacent to the location where the energy harvester module 130 is installed. This is because it can cause deformation or destruction of body tissues made of protein. The temperature information of the main power module 120 and the current information of the energy harvester module 130 are also for the same reason.
진동센서부(145)는 사용자 신체의 진동(또는 움직임)을 감지하도록 구성된다. 이는 사용자의 신체 활동과 연동된다. 가령, 사용자가 취침 중인 경우에는 진동이 상대적으로 낮을 수 있으나, 사용자가 야외 활동 중인 경우에는, 진동이 상대적으로 높을 수 있고, 에너지 하베스터모듈(130)에 의한 발전이 활발하게 수행될 수 있다. The vibration sensor unit 145 is configured to detect vibration (or movement) of the user's body. This is linked to the user's physical activity. For example, when the user is sleeping, the vibration may be relatively low, but when the user is active outdoors, the vibration may be relatively high, and power generation by the energy harvester module 130 may be actively performed.
만약, 사용자가 무선충전모듈(10)을 통해 충전 중인 상태에서, 진동값이 기준값 이상일 경우에는 무선충전모듈(10)에 의한 제2 충전모드의 동작을 중지하도록 사용자에게 안내할 수 있다. 이는 사용자단말(20)을 통해서 알림이 제공될 수 있다. If the user is charging through the wireless charging module 10 and the vibration value is higher than the reference value, the user may be instructed to stop operating the second charging mode by the wireless charging module 10. This notification may be provided through the user terminal 20.
무선충전모듈(10)은 안정적인 충전(제2 충전모드)을 위해, 별도의 신체고정장치를 착용한 상태에서 충전이 수행될 수 있는 바, 제2 충전모드가 수행 중인 경우에도, 사용자는 활발한 운동을 할 수 있다. The wireless charging module 10 can be charged while wearing a separate body restraint device for stable charging (second charging mode), and even when the second charging mode is being performed, the user can exercise actively. can do.
한편, 제어모듈(140)은 BMS부(144)를 포함할 수 있다. BMS부(144)는 메인전원모듈(120) 및 에너지 하베스터모듈(130) 각각에 구비될 수 있으나, 본원에서는 설명의 편의를 위해, 제어모듈(140)에 BMS부(144)가 포함되는 것으로 규정하였다. Meanwhile, the control module 140 may include a BMS unit 144. The BMS unit 144 may be provided in each of the main power module 120 and the energy harvester module 130, but herein, for convenience of explanation, it is defined that the BMS unit 144 is included in the control module 140. did.
BMS부(144)는 메인전원모듈(120) 및 에너지 하베스터모듈(130)의 상태를 모니터링한다. 특히, 메인전원모듈(120)의 충방전정보 및 잔존용량정보(State Of Charge, SOC)를 획득하여 사용자단말(20)로 전송하도록 구성된다. The BMS unit 144 monitors the status of the main power module 120 and the energy harvester module 130. In particular, it is configured to obtain charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module 120 and transmit them to the user terminal 20.
사용자는 사용자단말(20)을 통해, 메인전원모듈(120)의 현재 상태를 확인하고, 무선충전이 필요한 시기, 전자약(110)의 잔여사용시간 등을 예측할 수 있다. Through the user terminal 20, the user can check the current status of the main power module 120, predict when wireless charging is needed, the remaining use time of the electronic medicine 110, etc.
또한, BMS부(144)는 외부의 무선충전모듈(10)과 메인전원모듈(120)의 전기적 연결상태를 감지하며, 전기적 연결상태와 실시간 충전정보를 사용자단말로 제공하도록 구성될 수 있다. 무선충전의 특성상 무선충전모듈(10)의 무선전력공급부(미도시)와 메인전원모듈(120)의 무선전력수신부(124)가 상호 대응되도록 정위치하는 것이 필요하기 때문이다. Additionally, the BMS unit 144 may be configured to detect the electrical connection status of the external wireless charging module 10 and the main power module 120 and provide the electrical connection status and real-time charging information to the user terminal. This is because, due to the nature of wireless charging, it is necessary to position the wireless power supply unit (not shown) of the wireless charging module 10 and the wireless power receiving unit 124 of the main power module 120 to correspond to each other.
이들이 정위치되지 않는 경우, 사용자에게 이를 알려서, 사용자가 이들을 정위치하도록 강제하는 것이 필요하다. If they are not in place, it is necessary to notify the user and force the user to place them in place.
또한, BMS부(144)는 메인전원모듈(120)의 잔존용량정보가 기준값 이하로 떨어질 경우, 에너지 하베스터모듈(130)에 의한 충전을 유도할 수 있다. 무선충전모듈(10)을 사용하기 어려운 경우, 사용자의 움직임을 유도함으로써, 에너지 하베스터모듈(130)에 의한 충전을 유도하는 것이다. 본 발명에 따른 전기적 신경치료 시스템은 메인전원모듈(120) 및 에너지 하베스터모듈(130)을 하이브리드 방식으로 사용하는 바, 상기의 알람은 매우 유용할 수 있다. Additionally, the BMS unit 144 may induce charging by the energy harvester module 130 when the remaining capacity information of the main power module 120 falls below a reference value. When it is difficult to use the wireless charging module 10, charging by the energy harvester module 130 is induced by inducing the user's movement. Since the electrical nerve treatment system according to the present invention uses the main power module 120 and the energy harvester module 130 in a hybrid method, the above alarm can be very useful.
도 7을 참조하여, 본 발명에 따른 전기적 신경치료 시스템을 이용한 방법을 설명한다. 전술한 내용과 중복되는 설명은 생략한다. With reference to Figure 7, a method using the electrical nerve treatment system according to the present invention will be described. Descriptions that overlap with the above are omitted.
본 방법은 단계(S110) 내지 단계(S130)으로 구성될 수 있다. This method may consist of steps S110 to S130.
단계(S110)는 전자약(110)으로부터 미리 설정된 전기자극이 사용자 신경에 인가되면서 메인전원모듈(120)의 방전모드가 수행되는 단계이다. Step (S110) is a step in which the discharge mode of the main power module 120 is performed while a preset electrical stimulation from the electroweak 110 is applied to the user's nerves.
단계(S120)는 에너지 하베스터모듈(130)에 진동이 인가되어 자가발전이 수행되는 단계로서, 메인전원모듈(120)을 충전시키는 제1 충전모드가 수행되는 단계이다. 사용자가 일상 생활을 하면서, 자연스럽게 마찰소자모듈(132)에 진동이 인가됨에 따라, 비선형적인 전기에너지가 생산된다. Step S120 is a step in which self-power generation is performed by applying vibration to the energy harvester module 130, and is a step in which a first charging mode for charging the main power module 120 is performed. As the user goes about his or her daily life, vibration is naturally applied to the friction element module 132, thereby producing non-linear electrical energy.
물론, 제1 충전모드는 단계(S110)의 방전모드와 동시에 수행될 수 있다. Of course, the first charging mode can be performed simultaneously with the discharging mode in step S110.
단계(S130)는 메인전원모듈(120)의 잔존용량정보가 미리 설정된 기준값 이하로 떨어진 경우, 외부의 무선충전모듈로부터 무선으로 전원을 공급받는 제2 충전모드가 수행되는 단계이다. 여기서, 제2 충전모드가 수행되는 경우, 메인전원모듈(120)로부터 전자약으로 전원공급이 중지되는 방전중지모드로 동작될 수 있다. In step S130, when the remaining capacity information of the main power module 120 falls below a preset reference value, a second charging mode in which power is supplied wirelessly from an external wireless charging module is performed. Here, when the second charging mode is performed, it may be operated in a discharge stop mode in which power supply from the main power module 120 to the electroweak is stopped.
전자약 외부에 연결되는 에너지 하베스터모듈Energy harvester module connected to the outside of the electrochemical device
이하에서는 도 8 내지 15를 참조하여, 본 발명에 따른 에너지 하베스터모듈을 설명한다. 이하에서 설명하는 에너지 하베스터모듈(130)은 전술한 전기적 신경치료 시스템의 다른 실시예로 구분될 수 있다. 전술한 실시예는 에너지 하베스터모듈(200)이 전자약(110) 하우징에 함께 위치되는 구조를 전제로 설명하였으나, 이하에서 설명하는 다른 실시예는 에너지 하베스터모듈(230)이 전자약(210) 외부에 독립적으로 위치되는 구조이다. Below, with reference to FIGS. 8 to 15, the energy harvester module according to the present invention will be described. The energy harvester module 130 described below may be divided into different embodiments of the electrical nerve treatment system described above. The above-described embodiment was described on the premise that the energy harvester module 200 is located together in the electroweak 110 housing. However, in another embodiment described below, the energy harvester module 230 is located outside the electroweak 210. It is a structure that is located independently.
전술한 개별 구성에 대한 중복된 설명은 생략하도록 한다. Redundant descriptions of the individual components described above will be omitted.
도 8을 참조하면, 에너지 하베스터모듈(230)은 전자약(210) 외부에 위치된다는 점에서 전술한 제1 실시예와 구분될 수 있다. 즉, 에너지 하베스터모듈(230)의 수명이 다하거나, 교체가 필요한 경우, 전자약(210)과는 별개로, 에너지 하베스터모듈(230) 만을 교체하여 사용할 수 있는 구조이다. Referring to FIG. 8, the energy harvester module 230 may be distinguished from the above-described first embodiment in that it is located outside the electroweak 210. That is, when the lifespan of the energy harvester module 230 expires or replacement is required, only the energy harvester module 230 can be replaced and used separately from the electroweak 210.
참고로, 전자약(210) 하우징 내부에는 제어모듈(240) 및 메인전원모듈(220)이 구비된다. For reference, a control module 240 and a main power module 220 are provided inside the electroweak 210 housing.
에너지 하베스터모듈(230)은 발전기(233), 하베스터부(235) 및 케이스(231)를 포함한다. The energy harvester module 230 includes a generator 233, a harvester unit 235, and a case 231.
케이스(231)는 에너지 하베스터모듈(230)의 외관을 형성하며, 내부 부품을 보호하는 구성이다. 강한 외력으로부터 내부를 보호하기 위해, 티타늄 재질로 형성되는 것이 바람직하다. 케이스(231)의 일측에는 피드-스루(236)가 형성되며, 피드-스루(236)를 통해, 제1 채널라인(237)이 전자약(210) 방향으로 연장 형성된다. The case 231 forms the exterior of the energy harvester module 230 and protects the internal components. In order to protect the interior from strong external forces, it is preferably made of titanium. A feed-through 236 is formed on one side of the case 231, and a first channel line 237 is formed to extend in the direction of the electroweak 210 through the feed-through 236.
발전기(233)는 마찰소자모듈(232)을 이용하여 비선형적 전기에너지를 발생시킨다. 내부의 마찰소자모듈(232)을 이용하여 전기에너지를 발생시키는 원리는 도 3에 설명된 바와 같다. The generator 233 generates non-linear electrical energy using the friction element module 232. The principle of generating electric energy using the internal friction element module 232 is as explained in FIG. 3.
마찰소자모듈(232)은 마찰전기를 발생시킬 수 있는 공지된 어떠한 소자라도 모두 사용될 수 있다. 본 발명에 적용 가능한 소자 예시는 아래와 같다. 이는 단순한 예시인 바, 이에 제한되는 것은 아니다. The friction element module 232 may be any known element capable of generating triboelectricity. Examples of devices applicable to the present invention are as follows. This is a simple example, and is not limited thereto.
1) ZnO nanorods@conductive 카본 블랙 나노복합체 기반 유연 마찰전기를 통한 에너지 변환 및 저장 통합 시스템, 나노발전기와 슈퍼커패시터;1) Integrated system for energy conversion and storage through flexible triboelectricity, nanogenerator and supercapacitor based on ZnO nanorods@conductive carbon black nanocomposite;
2) 마찰 전기를 통한 에너지 수확 및 환경 모니터링을 위한 유연한 전도성 직물의 Co/Zn 바이메탈 유기 프레임워크 타원형 나노시트;2) Co/Zn bimetallic organic framework elliptical nanosheets in flexible conductive fabrics for energy harvesting and environmental monitoring through triboelectricity;
3) Double-Layered 전극 효과 기반의 고성능 마찰전기 나노발전기;3) High-performance triboelectric nanogenerator based on double-layered electrode effect;
4) 마찰 전기와 열전기를 결합하여, 고급 스마트 센서를 위한 마찰열을 통해 하이브리드 나노발전기(슬라이딩);4) Hybrid nanogenerator (sliding) by combining triboelectricity and thermoelectricity, through frictional heat for advanced smart sensors;
하베스터부(235)는 발전기(233)로부터 제공된 전기에너지를 미리 설정된 방식으로 임시 저장하는 구성이다. 발전기(233)의 마찰소자모듈(232)을 통해 발전된 비선형적 전기 에너지를 다단계로 구성된 다중 에너지 저장소(235a, 235b, 235c)에 순차적으로 저장시키고, 다중 에너지 저장소(235a, 235b, 235c)에 저장된 에너지를 공급한다. 이 때, 다중 에너지 저장소(220)는 배터리(또는 전지)와는 상이한 구성으로서, 전자회로와 일체로 구성된 에너지 저장 공간이 작은 에너지 저장소를 의미한다. 도 9에 도시된 하베스터부(235)는 예시적인 구조로써, 다중 에너지 저장소(235a, 235b, 235c)의 개수는 설계자의 선택에 따라 최적으로 설계될 수 있다. The harvester unit 235 is configured to temporarily store electrical energy provided from the generator 233 in a preset manner. The non-linear electric energy generated through the friction element module 232 of the generator 233 is sequentially stored in the multi-stage multi-energy storage (235a, 235b, 235c), and the energy stored in the multi-energy storage (235a, 235b, 235c) Provides energy. At this time, the multi-energy storage 220 is a different configuration from a battery (or battery) and refers to an energy storage with a small energy storage space integrated with an electronic circuit. The harvester unit 235 shown in FIG. 9 is an exemplary structure, and the number of multiple energy storages 235a, 235b, and 235c can be optimally designed according to the designer's selection.
하베스터부(235)는 제1 채널라인(237)과 연결되는 바, 제1 채널라인(237)을 통해 전자약(210) 측에 전기에너지를 실시간 제공할 수 있다. The harvester unit 235 is connected to the first channel line 237, and can provide real-time electrical energy to the electroweak 210 through the first channel line 237.
도 10을 참조하면, 전자약(210)은 목표하는 신경(도 3에서는 예시적으로 '미주신경'이라 함)에 접촉하는 제2 채널라인(202)이 구비된다. 에너지 하베스터모듈(230)로부터 제공된 전기에너지는 이차전지(222)-제2 채널라인(202)을 거쳐 사용자 체내의 신경에 제공될 수 있다. Referring to FIG. 10, the electromagnetic drug 210 is provided with a second channel line 202 that contacts the target nerve (illustratively referred to as the 'vagus nerve' in FIG. 3). Electrical energy provided from the energy harvester module 230 may be provided to the nerves in the user's body through the secondary battery 222 and the second channel line 202.
제1 채널라인(237)은 커넥터부(226)를 통해 연결될 수 있다. 커넥터부(226)를 기준으로, 전자약(210)과 연결된 부분을 제1 채널라인A(237a)라 하고, 에너지 하베스터모듈(230)과 연결된 부분을 제1 채널라인B(237b)로 구분한다. The first channel line 237 may be connected through the connector portion 226. Based on the connector portion 226, the part connected to the electroweak 210 is called a first channel line A (237a), and the part connected to the energy harvester module 230 is called a first channel line B (237b). .
제1 채널라인A(237a) 및 제1 채널라인B(237b)는 커넥터부(226)를 통해 상호 연결된다. 이와 같이, 커넥터부(226)를 구비함에 따라, 에너지 하베스터모듈(230)의 교체가 용이할 수 있다. The first channel line A (237a) and the first channel line B (237b) are connected to each other through the connector portion 226. In this way, by providing the connector portion 226, the energy harvester module 230 can be easily replaced.
도 10에서는 에너지 하베스터모듈(230)의 변형예를 도시한다. 전기에너지가 제1 채널라인A(237a) 및 제1 채널라인B(237b)을 통해서만 공급되는 것이 아니라, 무선충전방식도 가능한 구성을 도시한다. Figure 10 shows a modified example of the energy harvester module 230. It shows a configuration in which electrical energy is not only supplied through the first channel line A (237a) and first channel line B (237b), but also a wireless charging method is possible.
이를 위해, 에너지 하베스터모듈(230)에는 무선전력송신부(238)가 구비되며, 전자약(210) 측에는 무선전력수신부(224)가 구비될 수 있다. 여기서, 전자약(210) 측의 무선전력수신부(224)는 외부의 무선충전모듈(10)과 겸용으로 사용되는 것이 바람직하다. 무선충전모듈(10)에 의한 충전과는 달리, 에너지 하베스터모듈(230)에 의한 무선충전은 상시 충전이라는 점에서 구별된다. 물론, 충전 조건, 방식 및 주기 등은 관리자의 선택에 따라, 설정될 수 있다. For this purpose, the energy harvester module 230 may be provided with a wireless power transmission unit 238, and the electroweak 210 may be provided with a wireless power reception unit 224. Here, the wireless power receiver 224 on the electroweak 210 side is preferably used in conjunction with the external wireless charging module 10. Unlike charging using the wireless charging module 10, wireless charging using the energy harvester module 230 is distinguished in that it is constant charging. Of course, charging conditions, methods, and cycles can be set according to the administrator's selection.
전자약(210)의 이차전지(222)는 커패시터부(226)와 연결될 수 있다. 커패시터부(226)는 이차전지(222)에 비해, 상대적으로 충전용량이 그리 크지는 않을 수 있다. 커패시터부(226)는 충전용량이 그리 크지 않아도, 물리적으로 전자를 흡착하기 때문에, 구조 변화도 없이 생체 내부에서 안정적으로 사용될 수 있다. 또한, 매우 빠른 시간에 전자의 방출이 가능한 바, 고출력에 적용될 수 있는 바, 전자약(210)의 대체전원 또는 보조전원으로 매우 효과적으로 사용될 수 있다. The secondary battery 222 of the electroweak 210 may be connected to the capacitor unit 226. The capacitor unit 226 may not have a relatively large charging capacity compared to the secondary battery 222. Even though the capacitor unit 226 does not have a very large charge capacity, it can be stably used inside a living body without any structural change because it physically absorbs electrons. In addition, since electrons can be emitted in a very fast time and can be applied to high output, it can be used very effectively as an alternative or auxiliary power source for the electroweak 210.
도 11에는 증폭댐퍼(233c)가 구비된 발전기(233)를 개략적으로 도시한다. Figure 11 schematically shows a generator 233 equipped with an amplification damper 233c.
증폭댐퍼(233c)는, 미리 연산된 위치에 결합되되, 사용자의 움직임을 고려하여, 마찰소자의 미세 움직임을 지속시키도록 형성된다. 도 11에 도시된 바와 같이, 마찰소자모듈의 최외곽층에 형성될 수 있으며, 복수로 형성되되, 일정 간격에 대응되는 크기로 형성될 수 있다. The amplifying damper 233c is coupled to a pre-calculated position and is formed to sustain the fine movement of the friction element, taking into account the user's movement. As shown in FIG. 11, it can be formed on the outermost layer of the friction element module, and can be formed in plural numbers, with sizes corresponding to regular intervals.
사람은 평상시 여러 가지 움직임을 통해 활동을 하게 되는데, 이러한 일상 생활에서의 움직임에 의해 증폭댐퍼(233c)가 부착된 발전기(233)는 발전을 하게 되며, 움직임이 일어나는 동안 또는 움직임이 정지되는 순간에도 증폭 댐퍼(233c)는 이격된 공간 내에서 마찰소자의 미세 움직임을 지속시켜 발전 특성을 극대화시킬 수 있다. People usually engage in activities through various movements, and due to these movements in daily life, the generator 233 to which the amplification damper 233c is attached generates power, and even during movement or at the moment when movement is stopped. The amplification damper 233c can maximize power generation characteristics by continuing the fine movement of the friction element within the spaced apart space.
도 11에 도시된 바와 같이, 발전기(233)는 멀티 레이어로 구성될 수 있다. 멀티 레이어 중 가장 기본인 이중 레이어를 예로 들어 설명한다. As shown in FIG. 11, the generator 233 may be composed of multiple layers. This will be explained using the double layer, the most basic of multi-layers, as an example.
도 11의 멀티 레이어인 이중 레이어는 제1 레이어(233a) 및 제2 레이어(233b)로 구분된다. 제1 및 제2 레이어(233a, 233b)의 접촉시 마찰에 의해 전기에너지가 발생된다. The multi-layer double layer of FIG. 11 is divided into a first layer 233a and a second layer 233b. Electrical energy is generated by friction when the first and second layers 233a and 233b come into contact.
도 12를 참조하면, 사용자의 움직임을 고려한 발전기의 배치형태를 도시한다. 도 12에 도시된 형태는 사용자의 생활패턴을 고려한 것으로써, 자주 걷는 사람의 경우, 걷는 동작에 최적화된 발전기 배치형태를 제공하는 것이 바람직하다. Referring to Figure 12, it shows the arrangement of the generator considering the user's movement. The form shown in FIG. 12 takes into account the user's lifestyle pattern, and for people who frequently walk, it is desirable to provide a generator arrangement optimized for walking motion.
즉, 외력이 주로 인가되는 방향(힘의 방향을 의미함)과 발전기(233) 내의 멀티 레이어(233a, 233b)의 배치방향을 상호 일치시킴으로써, 인가된 외력이 멀티 레이어(233a, 233b)의 마찰에 최대한 사용되도록 유도한다. That is, by matching the direction in which the external force is mainly applied (meaning the direction of force) and the arrangement direction of the multi-layers 233a and 233b in the generator 233, the applied external force causes friction of the multi-layers 233a and 233b. Encourage it to be used as much as possible.
이러한 경사각도(θ)는 사용자의 보폭을 기반으로 연산될 수 있다. 사용자가 걷는 상황에서, 사용자의 보폭은 사용자 몸의 경사에 영향을 주기 때문이다. 사용자마다 신체조건이 상이하며, 보폭 역시 상이한 바, 관리자는 해당 사용자에 최적화된 경사각도(θ)를 설정할 수 있다. This inclination angle (θ) can be calculated based on the user's stride length. This is because in a situation where the user is walking, the user's stride length affects the inclination of the user's body. Since each user's physical condition is different and the stride length is also different, the administrator can set the inclination angle (θ) optimized for the user.
또한, 멀티 레이어의 면적은, 사용자의 움직임 빈도 및 시간을 고려하여 결정될 수 있다. 움직임이 많은 사용자의 경우, 멀티 레이어의 면적을 상대적으로 작게 형성하여도, 충분히 원하는 충전용량을 확보할 수 있다. 움직임이 적은 사용자의 경우, 멀티 레이어의 면적을 크게 형성함으로써, 마찰 면적을 증가시킬 수 있다. 멀티 레이어의 면적은 길이(l)와 폭(d)의 조절을 통해 수행될 수 있다. Additionally, the area of the multi-layer may be determined by considering the frequency and time of the user's movement. For users who move a lot, the desired charging capacity can be secured even if the area of the multi-layer is relatively small. For users with little movement, the friction area can be increased by forming a large area of the multi-layer. The area of the multi-layer can be achieved by adjusting the length (l) and width (d).
경사각도(θ) 및 레이어의 면적은 스마트워치 등을 통해, 사용자의 걸음특성, 행동특성 자료를 확보하여, 사용자에게 최적화된 값으로 설정되는 것이 바람직하다. It is desirable that the inclination angle (θ) and the area of the layer are set to values optimized for the user by securing data on the user's walking characteristics and behavioral characteristics through a smart watch, etc.
도 13은 본 발명인 에너지 하베스터모듈이 적용된 전기적 신경치료 시스템의 개략적인 모식도이다. 도 3에 도시된 개념도와 매칭된다. Figure 13 is a schematic diagram of an electrical nerve treatment system to which the energy harvester module of the present invention is applied. It matches the conceptual diagram shown in FIG. 3.
전자약(210)은 2개의 채널라인이 결합되도록 형성된다. 에너지 하베스터모듈(230)과 연결되는 제1 채널라인(237)과, 신경과 결합되는 제2 채널라인(202)으로 구성된다. 제2 채널라인(202)의 팁(202a)은 신경 부위와 접촉한다. The electroweak 210 is formed so that two channel lines are combined. It consists of a first channel line 237 connected to the energy harvester module 230, and a second channel line 202 connected to the nerve. The tip 202a of the second channel line 202 contacts the nerve area.
도 13에 도시된 형태는 본 발명에 따른 에너지 하베스터모듈(230) 뿐만 아니라, 전자약(210)의 예시적 형태를 도시하는 바, 다른 형태 및 크기로 설계될 수 있다. 에너지 하베스터모듈(230)의 형태 역시, 평면을 기준으로 원형으로 형성될 수도 있다. The form shown in FIG. 13 shows an exemplary form of the electroweak 210 as well as the energy harvester module 230 according to the present invention, and may be designed in different shapes and sizes. The shape of the energy harvester module 230 may also be circular with respect to a plane.
도 14를 참조하여, 멀티 레이어(230')의 변형예를 설명한다. 도 14에 도시된 변형예는 상호 대면하는 측(마찰하는 측을 의미함)에 방향성을 부여한 구조이다. 대면하는 면에는 각각 단위마찰소자(239a, 239b)가 복수로 형성된다. With reference to FIG. 14, a modified example of the multi-layer 230' will be described. The modified example shown in FIG. 14 is a structure in which directionality is given to the sides that face each other (meaning the sides that rub against each other). A plurality of unit friction elements 239a and 239b are formed on the facing surfaces, respectively.
상부의 제1 레이어(233a) 및 제2 레이어(233b) 각각에 형성된 단위마찰소자(239a, 239b)는 상호 대응되는 형상이다. 단위마찰소자(239a, 239b)는 소정의 경사를 갖도록 형성된다. 이는 전술한 경사각도(θ)와 동일한 개념으로 볼 수 있다. 사용자 신체의 각도를 고려하여, 단위마찰소자(239a, 239b)의 경사각을 설계한 것이다. 단위마찰소자(239a, 239b)의 길이(a), 개수, 위치 및 간격 등은 설계자의 선택에 따라, 사용자에게 최적화된 형태로 구성될 수 있다. Unit friction elements 239a and 239b formed on each of the upper first layer 233a and second layer 233b have shapes corresponding to each other. The unit friction elements 239a and 239b are formed to have a predetermined slope. This can be viewed as the same concept as the inclination angle (θ) described above. Considering the angle of the user's body, the inclination angle of the unit friction elements 239a and 239b is designed. The length (a), number, position, and spacing of the unit friction elements 239a and 239b can be configured in a form optimized for the user according to the designer's selection.
여기서, 멀티 레이어(230') 및 케이스(231) 사이의 잔여거리(b)는 단위마찰소자(239a, 239b)의 빗변길이를 고려한 것이다. 즉, 잔여거리(b)는 슬라이딩을 간섭하지 않을 정도로 여유롭게 형성되는 것이 바람직하다. Here, the remaining distance (b) between the multi-layer 230' and the case 231 takes into account the hypotenuse length of the unit friction elements 239a and 239b. In other words, it is desirable that the remaining distance (b) is sufficiently formed to not interfere with sliding.
전자약 모니터링 시스템Electronic drug monitoring system
*이하에서는, 도 16 내지 22를 참조하여, 본 발명에 따른 전자약 모니터링 시스템(300)을 설명한다. 전술한 세부 구성들에 대한 중복된 설명은 생략한다. *In the following, the electroweak monitoring system 300 according to the present invention will be described with reference to FIGS. 16 to 22. Redundant description of the detailed configurations described above will be omitted.
전자약 모니터링 시스템(300)은 전자약(310), 메인전원모듈(320), 에너지 하베스터모듈(330) 및 제어모듈(340)로 구성된다. The electroweak monitoring system 300 consists of an electroweak 310, a main power module 320, an energy harvester module 330, and a control module 340.
제어모듈(340)은 전자약(310), 메인전원모듈(320) 및 에너지 하베스터모듈(330)의 상태확인 및 동작제어를 수행한다. 또한, 사용자단말(20)과 무선통신이 가능한 통신부(341)가 구비된다. 통신부(341)는 네트워크망과 무선/유선 연결되며, 획득한 정보를 사용자단말(20)로 전송하도록 구성된다. The control module 340 checks the status and controls the operation of the electroweak 310, the main power module 320, and the energy harvester module 330. In addition, a communication unit 341 capable of wireless communication with the user terminal 20 is provided. The communication unit 341 is wirelessly/wiredly connected to the network and is configured to transmit the obtained information to the user terminal 20.
본 발명의 무선통신 관련하여, 본 발명은 PCS(Personal Communication System), GSM(Global System for Mobile communications), PDC(Personal Digital Cellular), PHS(Personal Handyphone System), PDA(Personal Digital Assistant), IMT(International Mobile Telecommunication)-2000, CDMA(Code Division Multiple Access)-2000, W-CDMA(W-Code Division Multiple Access), Wibro(Wireless Broadband Internet) 단말, 스마트폰(smartphone), 스마트 패드(smartpad), 타블렛 PC(Tablet PC) 등과 같은 모든 종류의 핸드헬드(Handheld) 기반의 모든 무선통신장치 및 거치형 PC, 노트북과 같은 컴퓨팅 장치가 이용될 수 있고, 상기의 분산 어플리케이션은 컴퓨터 프로그램 형태로 구현되며 읽고 쓰기가 가능한 기록매체에 기록되어 단말기에 탑재될 수 있다. In relation to wireless communication of the present invention, the present invention includes Personal Communication System (PCS), Global System for Mobile communications (GSM), Personal Digital Cellular (PDC), Personal Handyphone System (PHS), Personal Digital Assistant (PDA), and IMT ( International Mobile Telecommunication)-2000, CDMA (Code Division Multiple Access)-2000, W-CDMA (W-Code Division Multiple Access), Wibro (Wireless Broadband Internet) terminal, smartphone, smartpad, tablet All types of handheld-based wireless communication devices such as PCs (Tablet PCs) and computing devices such as stationary PCs and laptops can be used, and the above distributed applications are implemented in the form of computer programs and can be read and written. It can be recorded on a possible recording medium and mounted on the terminal.
또한, 본 발명에 따른 시스템은, 네트워크를 기반으로 하는 바, 네트워크는 단말들 및 서버들과 같은 각각의 노드 상호 간에 정보 교환이 가능한 연결 구조를 의미한다. 이러한 네트워크(network)의 일 예에는 3GPP(3rd Generation Partnership Project) 네트워크, LTE(Long Term Evolution) 네트워크, WIMAX(World Interoperability for Microwave Access) 네트워크, 인터넷(Internet), LAN(Local Area Network), Wireless LAN(Wireless Local Area Network), WAN(Wide Area Network), PAN(Personal Area Network), 블루투스(Bluetooth) 네트워크, 위성 방송 네트워크, 아날로그 방송 네트워크, DMB(Digital Multimedia Broadcasting) 네트워크, WiFi 등이 포함되나, 이에 한정되지는 않는다.Additionally, the system according to the present invention is based on a network, and the network refers to a connection structure that allows information exchange between nodes such as terminals and servers. Examples of such networks include the 3rd Generation Partnership Project (3GPP) network, Long Term Evolution (LTE) network, World Interoperability for Microwave Access (WIMAX) network, Internet, Local Area Network (LAN), and Wireless LAN. (Wireless Local Area Network), WAN (Wide Area Network), PAN (Personal Area Network), Bluetooth network, satellite broadcasting network, analog broadcasting network, DMB (Digital Multimedia Broadcasting) network, WiFi, etc. It is not limited.
도 16을 참조하면, 본 발명은 제어모듈(340)을 통해 획득된 정보를 사용자단말(20)에 전송하는 것을 특징으로 한다. 통신부(341)는 양방향 통신이 가능한 트랜시버(transceiver)로 구성될 수도 있다. Referring to FIG. 16, the present invention is characterized by transmitting information obtained through the control module 340 to the user terminal 20. The communication unit 341 may be composed of a transceiver capable of two-way communication.
도 17을 참조하면, 메인전원모듈(320)의 이차전지(322)는 보조전원부(324)와 결선되어 전력을 제공받도록 구성될 수 있다. 보조전원부(324)는 캐패시터를 포함한다. 변형예로써, 보조전원부(324)는 통신부(341)와 결선될 수 있다. 이 때, 통신부(341)는 상용 Bluetooth Low Energy(BLE) 보드로 구성되어 사용자단말(20)과 근거리 통신이 수행되도록 구성될 수 있다. Referring to FIG. 17, the secondary battery 322 of the main power module 320 may be configured to receive power by being connected to the auxiliary power supply unit 324. The auxiliary power unit 324 includes a capacitor. As a modified example, the auxiliary power unit 324 may be connected to the communication unit 341. At this time, the communication unit 341 may be configured with a commercial Bluetooth Low Energy (BLE) board to perform short-distance communication with the user terminal 20.
도 18을 참조하여, 본 발명의 제어모듈(340)을 설명한다. With reference to FIG. 18, the control module 340 of the present invention will be described.
제어모듈(340)은 제1 상태관리부(342), 제2 상태관리부(343), 정상동작판단부(344) 및 무선충전연산부(345)를 포함하며, 이들은 모두 통신부(341)와 연결되어 상호 정보를 주고받도록 구성된다. The control module 340 includes a first status management unit 342, a second status management unit 343, a normal operation determination unit 344, and a wireless charging operation unit 345, which are all connected to the communication unit 341 and interact with each other. It is designed to exchange information.
제1 상태관리부(342)는 메인전원모듈(320)의 상태를 관리하며, 메인전원모듈(320)의 충방전정보 및 잔존용량정보(State Of Charge, SOC)를 획득하여 저장하도록 구성된다. 메인전원모듈(320)의 상태는, 메인전원모듈(320)에 포함된 이차전지(322)의 모든 상태를 의미하는 광범위한 개념이다. The first state management unit 342 manages the state of the main power module 320 and is configured to obtain and store charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module 320. The state of the main power module 320 is a broad concept meaning all states of the secondary battery 322 included in the main power module 320.
일 예시로써, 제1 상태관리부(342)는, 센싱된 잔존용량정보가 미리 설정된 기준값 이하일 때, 메인전원모듈(320)이 보조전원부(324)로부터 전력을 공급받도록 제어할 수 있다. 이를 위해, 보조전원부(324)의 잔존용량정보 역시 제1 상태관리부(342)에 의해 실시간 확인 가능하도록 설계되는 것이 바람직하다. As an example, the first state management unit 342 may control the main power module 320 to receive power from the auxiliary power unit 324 when the sensed remaining capacity information is below a preset reference value. To this end, it is desirable to design the remaining capacity information of the auxiliary power unit 324 so that it can also be checked in real time by the first status management unit 342.
제2 상태관리부(343)는 에너지 하베스터모듈(330)의 상태를 관리하며, 에너지 하베스터모듈(330)의 발생전력정보를 획득하여 저장하도록 구성된다. 에너지 하베스터모듈(330)은 사용자의 움직임에 의해 자가발전을 수행하는 바, 자가발전 수행이력이 자동으로 저장된다. 역으로, 제2 상태관리부(343)를 통해, 사용자의 움직임을 역추정이 가능하다. The second status management unit 343 manages the status of the energy harvester module 330 and is configured to obtain and store power information generated by the energy harvester module 330. The energy harvester module 330 performs self-power generation by the user's movement, and the self-power generation performance history is automatically saved. Conversely, the user's movement can be reversely estimated through the second state management unit 343.
정상동작판단부(344)는 메인전원모듈(320) 및 에너지 하베스터모듈(330)의 정상동작을 판단한다. 메인전원모듈(320) 및 에너지 하베스터모듈(330)의 정상동작에 대한 정보는 제어모듈(340)에 미리 규정되어 있다. The normal operation determination unit 344 determines the normal operation of the main power module 320 and the energy harvester module 330. Information about the normal operation of the main power module 320 and the energy harvester module 330 is predefined in the control module 340.
본 발명은 사용자의 신경에 전기적신호를 인가하는 전자약을 포함하는 바, 사용자 신체보호 및 사고발생을 방지하기 위해, 정상동작을 판단하는 것이 매우 중요한 기능이다. The present invention includes an electromagnetic drug that applies electrical signals to the user's nerves, and determining normal operation is a very important function to protect the user's body and prevent accidents.
정상동작을 판단하는 일 예시로는, 메인전원모듈(320)의 잔존용량정보 및 에너지 하베스터모듈(330)의 발생전력정보를 이용하여, 미리 설정된 방식으로 통신부(341)와 사용자단말(20)의 무선통신 최대작동시간을 연산하여 정상동작을 판단하는 것이 있다. As an example of determining normal operation, the communication unit 341 and the user terminal 20 are connected in a preset manner using the remaining capacity information of the main power module 320 and the generated power information of the energy harvester module 330. There is a way to determine normal operation by calculating the maximum operating time of wireless communication.
메인전원모듈(320)의 잔존용량정보 및 에너지 하베스터모듈(330)의 발생전력정보가 충분함에도 불구하고, 통신부(341)와 사용자단말(20)의 무선통신 최대작동시간이 현저하게 낮은 값으로 연산된 경우, '비정상'으로 판단할 수 있다. 메인전원모듈(320) 및 에너지 하베스터모듈(330) 이외의 다른 소자에서 많은 전력이 소모됨을 의미할 수도 있고, 아니면, 무선통신오류로써, 정확한 정보의 송수신이 불가능한 상태일 수 있기 때문이다. Even though the remaining capacity information of the main power module 320 and the generated power information of the energy harvester module 330 are sufficient, the maximum wireless communication operation time between the communication unit 341 and the user terminal 20 is calculated to be a significantly low value. If this happens, it can be judged as ‘abnormal’. This may mean that a lot of power is consumed in other elements other than the main power module 320 and the energy harvester module 330, or it may be a wireless communication error that makes it impossible to transmit and receive accurate information.
이러한 문제를 바로 해결하는 것도 중요하나, 사용자에게 정상동작 여부를 신속하게 제공하는 것 역시 매우 중요하다. '비정상'일 경우, 사용자는 즉시, 전자약(310)의 동작을 강제 중지하도록 하는 것이다. It is important to immediately resolve these issues, but it is also very important to quickly provide users with information on whether the device is operating normally. In the case of 'abnormality', the user is forced to immediately stop the operation of the electronic medicine 310.
제어모듈(340)은 메인전원모듈(320)의 무선충전시기를 연산하여 사용자단말(20)로 제공하는 무선충전연산부(345)를 더 포함한다. The control module 340 further includes a wireless charging operation unit 345 that calculates the wireless charging timing of the main power module 320 and provides the wireless charging time to the user terminal 20.
본 발명의 전자약(310)의 잔존용량정보는 사용자 신체보호를 위한 가장 중요한 정보이다. 전자약(310)의 정상동작과 직결되기 때문이다. The remaining capacity information of the electronic drug 310 of the present invention is the most important information for protecting the user's body. This is because it is directly related to the normal operation of the electronic drug 310.
도 19를 참조하여 설명하면, 무선충전연산부(345)는 메인전원모듈(320) 및 에너지 하베스터모듈(330)로부터 각각 해당 정보를 제공받는다. 실시간 정보를 제공받는 것이 바람직하나, 소정의 주기 및 조건을 설정할 수 있다. 19, the wireless charging operation unit 345 receives corresponding information from the main power module 320 and the energy harvester module 330, respectively. It is desirable to receive real-time information, but certain cycles and conditions can be set.
메인전원모듈(320)의 전력소모량, 메인전원모듈(320)의 잔존용량정보 및 에너지 하베스터모듈(330)의 발생전력정보를 이용하여, 메인전원모듈(320)의 무선충전시기를 판단한다. The wireless charging time of the main power module 320 is determined using the power consumption of the main power module 320, the remaining capacity information of the main power module 320, and the generated power information of the energy harvester module 330.
도 19에는 일 예시적인 방법이 도시된다. 19 shows an example method.
무선충전연산부(345)는 현재 메인전원모듈(320)의 잔존용량정보를 기준으로, '1차예상 사용가능시간'을 연산한다. 그 후, '1차예상 사용가능시간'을 기준으로, 에너지 하베스터모듈(330)의 예상발생전력정보를 연산하고, 이를 기반으로 2차예상 사용가능시간을 판단한다. The wireless charging operation unit 345 calculates the ‘first expected use time’ based on the current remaining capacity information of the main power module 320. Afterwards, based on the 'first expected available time', the expected generated power information of the energy harvester module 330 is calculated, and the second expected available time is determined based on this.
만약, 2차예상 사용가능시간이 소정의 값 이하일 경우, 절전모드가 필요한지 재판단을 수행한다. 절전모드의 수행은 사용자의 선택에 의해 설정되는 것이 바람직하다. 사용자가 현재 절전모드가 수행되는 중임을 인지하는 것이 중요하기 때문이다. If the secondary expected available time is less than a predetermined value, a re-determination is performed as to whether power saving mode is necessary. It is desirable that the power saving mode is set by the user's selection. This is because it is important for the user to recognize that power saving mode is currently in effect.
이를 위해, 제1 및 제2 상태관리부(342, 343)는, 획득된 정보를 시간정보와 연동하여 모두 저장하도록 구성될 수 있다. To this end, the first and second state management units 342 and 343 may be configured to store all acquired information in conjunction with time information.
이 때, 무선충전연산부(345)는 시간을 기준으로, 전자약(310)에서 인가되는 전기자극에 사용되는 전력소모량 및 사용자의 움직임에 따른 에너지 하베스터모듈(330)의 발생전력정보를 미리 설정된 방식으로 분석하여, 메인전원모듈(320)의 무선충전시기를 판단할 수 있다. At this time, the wireless charging operation unit 345 calculates the power consumption amount used for the electrical stimulation applied from the electromagnetic drug 310 and the power information generated by the energy harvester module 330 according to the user's movement based on time in a preset manner. By analyzing, it is possible to determine the wireless charging time of the main power module 320.
즉, 과거의 사용이력을 기반으로, 메인전원모듈(320)의 무선충전시기를 판단하는 것을 의미한다. 1일인 24시간을 기준으로, 특정시간에서의 전기자극에 사용되는 전력소모량 및 발생전력정보의 통계를 기반으로 예측하는 것이다. 예측 방식은 회귀분석과 같은 통계적 기법이 사용될 수도 있다. In other words, this means determining the wireless charging time of the main power module 320 based on past usage history. Based on 24 hours per day, predictions are made based on statistics on power consumption and generated power information used for electrical stimulation at a specific time. Forecasting methods may use statistical techniques such as regression analysis.
도 20을 참조하면, 본 발명의 제어모듈(410)에서 수집되는 세부정보들을 알 수 있다. 이러한 세부정보들은 사용자단말(20)에서 확인 가능하도록 구성된다. 사용자단말(20)이 스마트폰/스마트테블릿인 경우, 설치된 애플리케이션을 통해 확인 가능하다. Referring to FIG. 20, you can see detailed information collected from the control module 410 of the present invention. These detailed information are configured to be confirmed on the user terminal 20. If the user terminal 20 is a smartphone/smart tablet, it can be checked through an installed application.
제어모듈(410)은 체온센싱부(340a), 전지온도센싱부(340b), 전류센싱부(340c), 조직온도센싱부(340d), 혈류량센싱부(340e) 및 피드백신호센싱부(340f)로부터 해당 정보를 제공받는다. The control module 410 includes a body temperature sensing unit 340a, a battery temperature sensing unit 340b, a current sensing unit 340c, a tissue temperature sensing unit 340d, a blood flow sensing unit 340e, and a feedback signal sensing unit 340f. The information is provided from .
구체적으로, 체온센싱부(340a)에 의해 측정된 사용자의 체온정보, 전지온도센싱부(340b)에 의해 측정된 메인전원모듈(320)의 온도정보, 전류센싱부(340c)에 의해 측정된 에너지 하베스터모듈(330)의 전류정보, 조직온도센싱부(340d)에 의해 측정된 전자약(310)이 설치된 인접조직의 온도정보, 혈류량센싱부(330e)에 의해 측정된 전자약(310)이 설치된 인접혈관의 혈류량정보를 사용자단말(20)에 제공하도록 구성된다. Specifically, the user's body temperature information measured by the body temperature sensing unit 340a, the temperature information of the main power module 320 measured by the battery temperature sensing unit 340b, and the energy measured by the current sensing unit 340c. Current information of the harvester module 330, temperature information of adjacent tissues where the electromedicine 310 is installed measured by the tissue temperature sensing unit 340d, and electromedicine 310 installed measured by the blood flow sensing unit 330e. It is configured to provide blood flow information of adjacent blood vessels to the user terminal 20.
또한, 제어모듈(340)은 전기자극발생부(312)에 인가한 전기적신호에 대한 피드백신호를 분석하도록 구성될 수 있다. 이러한 피드백신호의 분석을 통해, 신경의 손상 여부 뿐만 아니라, 전기적신호의 전달상태까지 확인 가능하다. Additionally, the control module 340 may be configured to analyze a feedback signal for the electrical signal applied to the electrical stimulation generator 312. Through analysis of these feedback signals, it is possible to check not only whether the nerve is damaged, but also the transmission status of the electrical signal.
본 발명의 변형예로, 제어모듈(340)은 전기자극설정부(347)를 더 포함할 수 있다. 전기자극설정부(347)는 의료기관의 전자처방과 관련된 구성이다. As a modified example of the present invention, the control module 340 may further include an electrical stimulation setting unit 347. The electrical stimulation setting unit 347 is a component related to electronic prescriptions at medical institutions.
전자약(310)의 전기적신호는 세기, 패턴, 종류 등의 다양한 요소로 구성될 수 있다. 이를 '데이터세트'라고 명명할 수 있다. 이러한 데이터세트는 처방권한이 있는 관리자(전문가)에 의해서만 설정될 수 있다. 전자약(310)을 통해 치료를 하는 행위는 의료행위의 범주 내에 포함될 수 있기 때문이다. The electrical signal of the electroweak 310 may be composed of various elements such as intensity, pattern, and type. This can be named a ‘dataset’. These datasets can only be set up by administrators (experts) with prescribing authority. This is because the act of treating using electronic medicine 310 can be included within the scope of medical practice.
진료 및 전자처방은 사용자단말(20)을 통해 원격으로 수행될 수 있다. 사용자가 관리자로부터 새로운 전자처방을 제공받은 경우, 상기 전자처방에 대응하여 상기 전기자극의 강도, 주기 및 패턴을 포함하는 동작내용이 갱신된다. 즉, 새로운 데이터세트가 생성되며, 새로운 데이터세트의 내용대로 전기자극발생부(312)는 전기적신호를 인가하도록 구성된다. Medical treatment and electronic prescriptions can be performed remotely through the user terminal 20. When the user receives a new electronic prescription from the administrator, the operation content including the intensity, cycle, and pattern of the electrical stimulation is updated in response to the electronic prescription. That is, a new data set is created, and the electrical stimulation generator 312 is configured to apply an electrical signal according to the contents of the new data set.
도 22를 참조하면, 본 발명은 사용자단말(20) 및 서버를 통해 통신하는 구성을 제공한다. 전술한 바와 같이, 사용자단말(20)에 설치된 애플리케이션을 통해 수행될 수 있다. Referring to FIG. 22, the present invention provides a configuration for communicating through a user terminal 20 and a server. As described above, it can be performed through an application installed on the user terminal 20.
구체적으로, 사용자단말(20)로부터 로그인 요청이 수신되면, 메인전원모듈(320), 에너지 하베스터모듈(330) 및 전자약(310) 각각에 대한 사용자 인터페이스를 제공한다. 사용자는 이 중 어느 하나를 선택할 수 있으며, 선택된 항목에 대한 상태정보를 실시간으로 확인할 수 있다. Specifically, when a login request is received from the user terminal 20, a user interface is provided for each of the main power module 320, the energy harvester module 330, and the electronic drug 310. Users can select any one of these and can check status information for the selected item in real time.
먼저, 사용자에 의해 메인전원모듈(320)에 대한 사용자 인터페이스가 선택된 경우, 제1 상태관리부(342)로부터 획득된 메인전원모듈(320)의 충방전정보 및 현재의 잔존용량정보를 제공한다. First, when the user interface for the main power module 320 is selected by the user, charge/discharge information and current remaining capacity information of the main power module 320 obtained from the first status management unit 342 are provided.
사용자에 의해 에너지 하베스터모듈(330)에 대한 사용자 인터페이스가 선택된 경우, 제2 상태관리부(343)로부터 획득된 에너지 하베스터모듈(330)의 발생전력정보 및 발전효율정보를 제공한다. When the user interface for the energy harvester module 330 is selected by the user, the generated power information and power generation efficiency information of the energy harvester module 330 obtained from the second state management unit 343 are provided.
사용자에 의해 전자약(310)에 대한 사용자 인터페이스가 선택된 경우, 제3 상태관리부(344)로부터 획득된 전기자극정보를 시간순으로 제공하며, 신경에 인가된 전기자극의 피드백신호를 제공한다. 즉, 전기자극에 대한 이력정보를 제공하는 것을 의미한다. When the user interface for the electromedicine 310 is selected by the user, the electrical stimulation information obtained from the third state management unit 344 is provided in chronological order, and a feedback signal of the electrical stimulation applied to the nerve is provided. In other words, it means providing history information about electrical stimulation.
본 발명에서 상기 실시형태는 하나의 예시로서 본 발명이 여기에 한정되는 것은 아니다. 본 발명의 특허청구범위에 기재된 기술적 사상과 실질적으로 동일한 구성을 하고 동일한 작용효과를 이루는 것은 어떠한 것이라도 본 발명의 기술적 범위에 포함된다. In the present invention, the above embodiment is an example and the present invention is not limited thereto. Anything that has substantially the same structure and achieves the same effect as the technical idea described in the claims of the present invention is included in the technical scope of the present invention.

Claims (15)

  1. 전기적 신경치료 시스템으로서, As an electrical nerve treatment system,
    피하에 매립되며, 미리 설정된 전기자극을 신경에 인가하는 전자약; Electromedicine that is embedded under the skin and applies preset electrical stimulation to the nerves;
    상기 전자약에 전원을 제공하는 메인전원모듈로서, 외부의 무선충전모듈로부터 무선으로 전원을 공급받아 반복적인 충전이 가능한 이차전지로 구성된, 메인전원모듈; 및 A main power module that provides power to the electronic medicine, consisting of a secondary battery capable of repeated charging by receiving power wirelessly from an external wireless charging module; and
    마찰소자모듈을 이용하여 실시간 자가발전을 하도록 구성된 에너지 하베스터모듈로서, 상기 메인전원모듈과 전기적으로 연결되어 상기 메인전원모듈을 보조적으로 충전하는, 에너지 하베스터모듈; 을 포함하는, An energy harvester module configured to generate real-time self-generation using a friction element module, which is electrically connected to the main power module to auxiliary charge the main power module; Including,
    전기적 신경치료 시스템. Electrical neurotherapy system.
  2. 제 1항에 있어서, According to clause 1,
    상기 메인전원모듈은, The main power module is,
    상기 에너지 하베스터모듈로부터 전원을 공급받아 보조적으로 충전하는 제1 충전모드; 및 A first charging mode in which power is supplied from the energy harvester module and auxiliary charging is performed; and
    외부의 무선충전모듈로부터 무선으로 전원을 공급받아 충전하는 제2 충전모드; 를 포함하는 충전방식으로 구성되며, A second charging mode that charges by receiving power wirelessly from an external wireless charging module; It consists of a charging method that includes,
    상기 제1 및 제2 충전모드는, The first and second charging modes are:
    상호 택일적으로 동작하도록 구성되되, 상기 제2 충전모드가 상기 제1 충전모드에 우선하도록 설정된, Configured to operate alternatively, the second charging mode is set to take priority over the first charging mode,
    전기적 신경치료 시스템. Electrical neurotherapy system.
  3. 제 2항에 있어서, According to clause 2,
    상기 메인전원모듈은, The main power module is,
    상기 제1 충전모드로 동작시에는 방전모드로 동작되어 미리 설정된 전기자극을 신경에 인가하도록 구성되며, When operating in the first charging mode, it is operated in discharging mode and is configured to apply preset electrical stimulation to the nerve,
    상기 제2 충전모드로 동작시, 상기 전자약으로 전원공급이 중지되는 방전중지모드로 동작되되, 상기 제2 충전모드가 종료되면, 상기 전자약에 전원을 공급하는 방전모드로 동작되는, When operating in the second charging mode, it is operated in a discharging stop mode in which power supply to the electronic drug is stopped, and when the second charging mode is terminated, it is operated in a discharge mode that supplies power to the electronic drug,
    전기적 신경치료 시스템. Electrical neurotherapy system.
  4. 제 1항에 있어서, According to clause 1,
    상기 에너지 하베스터모듈의 전기적 용량은, The electrical capacity of the energy harvester module is,
    상기 메인전원모듈의 소모 전력량을 기준으로, 20 내지 30%의 전력량을 생성할 수 있는 용량으로 구성된, Consisting of a capacity capable of generating 20 to 30% of the power amount based on the power consumption of the main power module,
    전기적 신경치료 시스템. Electrical neurotherapy system.
  5. 제 1항에 있어서, According to clause 1,
    상기 메인전원모듈의 충방전 및 상기 에너지 하베스터모듈에 의한 충전을 제어하는 제어모듈; 을 더 포함하며, A control module that controls charging and discharging of the main power module and charging by the energy harvester module; It further includes,
    상기 제어모듈은, The control module is,
    가. 체온센싱부에 의해 측정된 사용자의 체온정보를 이용하여, 상기 체온정보가 미리 설정된 기준값 이상일 경우; go. Using the user's body temperature information measured by the body temperature sensing unit, when the body temperature information is greater than a preset standard value;
    나. 전지온도센싱부에 의해 측정된 상기 메인전원모듈의 온도정보를 이용하여, 상기 온도정보가 미리 설정된 기준값 이상일 경우; 및 me. Using the temperature information of the main power module measured by the battery temperature sensing unit, when the temperature information is greater than or equal to a preset reference value; and
    다. 전류센싱부에 의해 측정된 상기 에너지 하베스터모듈의 전류정보를 이용하여, 상기 전류정보가 미리 설정된 기준값 이상일 경우; 중 적어도 어느 하나에 해당할 경우, 상기 에너지 하베스터모듈에 의한 충전을 중단하도록 설정된, all. Using the current information of the energy harvester module measured by the current sensing unit, when the current information is greater than a preset reference value; If at least one of the following applies, it is set to stop charging by the energy harvester module,
    전기적 신경치료 시스템. Electrical neurotherapy system.
  6. 제 5항에 있어서, According to clause 5,
    상기 제어모듈은, The control module is,
    사용자단말과 통신 가능하도록 연결된 BMS부를 포함하며, It includes a BMS unit connected to enable communication with the user terminal,
    상기 BMS부는, The BMS department,
    상기 메인전원모듈의 충방전정보 및 잔존용량정보(State Of Charge, SOC)를 획득하여 상기 사용자단말로 전송하도록 구성된, Configured to obtain charge/discharge information and remaining capacity information (State Of Charge, SOC) of the main power module and transmit them to the user terminal,
    전기적 신경치료 시스템. Electrical neurotherapy system.
  7. 제 6항에 있어서, According to clause 6,
    상기 BMS부는, The BMS department,
    외부의 무선충전모듈 및 상기 메인전원모듈의 전기적 연결상태를 감지하며, 상기 전기적 연결상태와 실시간 충전정보를 사용자단말로 제공하는, Detects the electrical connection status of an external wireless charging module and the main power module, and provides the electrical connection status and real-time charging information to the user terminal.
    전기적 신경치료 시스템. Electrical neurotherapy system.
  8. 제 6항에 있어서, According to clause 6,
    상기 BMS부는, The BMS department,
    상기 메인전원모듈의 잔존용량정보가 미리 설정된 기준값 이하로 떨어지면, 상기 에너지 하베스터모듈에 의한 충전을 유도하는 알람을 사용자단말로 제공하는, When the remaining capacity information of the main power module falls below a preset reference value, an alarm to induce charging by the energy harvester module is provided to the user terminal.
    전기적 신경치료 시스템. Electrical neurotherapy system.
  9. 제 5항에 있어서, According to clause 5,
    상기 제어모듈은, The control module is,
    사용자 신체의 진동을 감지하는 진동센서부를 더 포함하며, It further includes a vibration sensor unit that detects vibration of the user's body,
    상기 진동센서부를 통해 센싱된 진동값이 미리 설정된 기준값 이상일 경우, If the vibration value sensed through the vibration sensor unit is greater than a preset standard value,
    상기 메인전원모듈이 외부의 무선충전모듈에 의해 충전 중인 상태이면, 상기 충전을 중지하고, 상기 에너지 하베스터모듈에 의해 상기 메인전원모듈을 충전하도록 제어하는, If the main power module is being charged by an external wireless charging module, the charging is stopped and the main power module is controlled to be charged by the energy harvester module.
    전기적 신경치료 시스템. Electrical neurotherapy system.
  10. 제 1항에 있어서,According to clause 1,
    상기 에너지 하베스터모듈은,The energy harvester module,
    상기 마찰소자모듈을 이용하여 전기에너지를 발생시키는 발전기를 포함하고,It includes a generator that generates electrical energy using the friction element module,
    상기 발전기는,The generator is,
    적어도 일부가 소정의 경사를 가지는 멀티 레이어로 구성된,Consisting of multiple layers, at least some of which have a predetermined slope,
    전기적 신경치료 시스템.Electrical neurotherapy system.
  11. 제 10항에 있어서,According to clause 10,
    상기 발전기는, The generator is,
    적어도 두 레이어를 포함하는 멀티 레이어(Multi-Layered)로 구성되며, It is composed of multi-layered containing at least two layers,
    상기 멀티 레이어는, The multi-layer is,
    사용자 신체의 전방을 향해, 미리 설정된 각도로 하향 경사지도록 사용자의 신체 내에 고정 매립된,Fixed and embedded within the user's body to be inclined downward at a preset angle, toward the front of the user's body,
    전기적 신경치료 시스템.Electrical neurotherapy system.
  12. 제 11항에 있어서,According to claim 11,
    상기 멀티 레이어는,The multi-layer is,
    제1 레이어; 및first layer; and
    상기 제1 레이어와 상하 방향으로 마주보도록 구성된 제2 레이어를 포함하고,It includes a second layer configured to face the first layer in an upward and downward direction,
    상기 제1 레이어 및 상기 제2 레이어의 각각에 형성된 단위마찰소자는 상호 대응되는 형상을 가지고, 소정의 경사를 갖도록 형성된,Unit friction elements formed on each of the first layer and the second layer have shapes corresponding to each other and are formed to have a predetermined inclination,
    전기적 신경치료 시스템.Electrical neurotherapy system.
  13. 제 11항에 있어서,According to claim 11,
    상기 멀티 레이어의 면적은,The area of the multi-layer is,
    사용자의 움직임 빈도 및 시간을 고려하여 결정되며, It is determined by considering the frequency and time of the user's movement,
    상기 멀티 레이어에서, In the multi-layer,
    상기 미리 설정된 각도는, 사용자의 보폭을 기반으로 연산되는, The preset angle is calculated based on the user's stride length,
    전기적 신경치료 시스템.Electrical nerve treatment system.
  14. 제 1항 내지 제 13항 중 어느 한 항에 따른 전기적 신경치료 시스템을 이용하는 방법으로서, A method using the electrical neurotherapy system according to any one of claims 1 to 13,
    (a) 메인전원모듈의 방전모드가 수행되는 단계; (a) a step in which the discharge mode of the main power module is performed;
    (b) 에너지 하베스터모듈에 진동이 인가되어 자가발전이 수행되는 단계로서, 상기 메인전원모듈을 충전시키는 제1 충전모드가 수행되는 단계; 및 (b) a step in which self-power generation is performed by applying vibration to the energy harvester module, in which a first charging mode for charging the main power module is performed; and
    (c) 상기 메인전원모듈의 잔존용량정보가 미리 설정된 기준값 이하로 떨어진 경우, 외부의 무선충전모듈로부터 무선으로 전원을 공급받는 제2 충전모드가 수행되는 단계; 를 포함하는, (c) when the remaining capacity information of the main power module falls below a preset reference value, performing a second charging mode in which power is supplied wirelessly from an external wireless charging module; Including,
    방법. method.
  15. 제 14항에 있어서, According to clause 14,
    상기 (c) 단계에서, In step (c) above,
    상기 제2 충전모드가 수행되는 경우, When the second charging mode is performed,
    상기 메인전원모듈로부터 상기 전자약으로 전원공급이 중지되는 방전중지모드로 동작되는, Operated in a discharge stop mode in which power supply from the main power module to the electroweak is stopped,
    방법. method.
PCT/KR2023/005535 2022-05-23 2023-04-24 Electrical nerve therapy system and method using same WO2023229237A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020220062814A KR102499592B1 (en) 2022-05-23 2022-05-23 Electrical neurostimulus system and method using the same
KR10-2022-0062814 2022-05-23

Publications (1)

Publication Number Publication Date
WO2023229237A1 true WO2023229237A1 (en) 2023-11-30

Family

ID=85220951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2023/005535 WO2023229237A1 (en) 2022-05-23 2023-04-24 Electrical nerve therapy system and method using same

Country Status (2)

Country Link
KR (2) KR102499592B1 (en)
WO (1) WO2023229237A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102499592B1 (en) * 2022-05-23 2023-02-14 오션스바이오 주식회사 Electrical neurostimulus system and method using the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8311632B2 (en) * 2008-02-25 2012-11-13 Autonomic Technologies, Inc. Devices, methods, and systems for harvesting energy in the body
KR20160044811A (en) * 2014-10-16 2016-04-26 삼성전자주식회사 Wearable sensor to monitor bio signal and method to monitor bio signal using wearable device
WO2016127130A1 (en) * 2015-02-06 2016-08-11 Nalu Medical, Inc. Medical apparatus including an implantable system and an external system
KR20210059958A (en) * 2019-11-18 2021-05-26 오션스바이오 주식회사 Wireless chargable electroceuticals for epilepsy treatment and control method thereof
KR102499592B1 (en) * 2022-05-23 2023-02-14 오션스바이오 주식회사 Electrical neurostimulus system and method using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102502453B1 (en) * 2017-09-25 2023-02-22 삼성전자주식회사 Method for controlling power on low power device and low power device performing the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8311632B2 (en) * 2008-02-25 2012-11-13 Autonomic Technologies, Inc. Devices, methods, and systems for harvesting energy in the body
KR20160044811A (en) * 2014-10-16 2016-04-26 삼성전자주식회사 Wearable sensor to monitor bio signal and method to monitor bio signal using wearable device
WO2016127130A1 (en) * 2015-02-06 2016-08-11 Nalu Medical, Inc. Medical apparatus including an implantable system and an external system
KR20210059958A (en) * 2019-11-18 2021-05-26 오션스바이오 주식회사 Wireless chargable electroceuticals for epilepsy treatment and control method thereof
KR102499592B1 (en) * 2022-05-23 2023-02-14 오션스바이오 주식회사 Electrical neurostimulus system and method using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WANG CHAN, SHI QIONGFENG, LEE CHENGKUO: "Advanced Implantable Biomedical Devices Enabled by Triboelectric Nanogenerators", NANOMATERIALS, MDPI, vol. 12, no. 8, 15 April 2022 (2022-04-15), pages 1366, XP093112231, ISSN: 2079-4991, DOI: 10.3390/nano12081366 *

Also Published As

Publication number Publication date
KR20230163923A (en) 2023-12-01
KR102499592B1 (en) 2023-02-14

Similar Documents

Publication Publication Date Title
WO2023229237A1 (en) Electrical nerve therapy system and method using same
EP3569044A1 (en) Electronic device
WO2016148356A1 (en) Mobile device and sensor control method therefor
WO2022025678A1 (en) Electronic device for evaluating sleep quality and method for operation in the electronic device
CN110794666A (en) ECG electrode for smart watch and smart watch
KR20210095606A (en) A control method of an electroceuticals for the treatment of epilepsy with an electromagnetic disturbance prevention function
CN102389300B (en) Intelligent heart rate locating and monitoring wristwatch with external power supply
WO2017105118A1 (en) Wearable smart key
WO2017057846A1 (en) Wear detection sensor and wearable device comprising same
KR102460342B1 (en) Energy harvester module and method using the same
CN109324495A (en) A kind of police system of multiple-protection based on smartwatch
KR102570253B1 (en) Electroceutical monitoring system
KR20240023312A (en) Secondary battery for exclusive use of electronic medicine and electronic medicine including same
KR20240023315A (en) Electrical neurotherapy system and method using the same
KR20230163625A (en) Secondary battery for exclusive use of electronic medicine and electronic medicine including same
KR20240022797A (en) Energy harvester module and method using the same
KR20240023317A (en) electroceuticals design system using AI
KR20230155633A (en) Electronic drug wireless charging system for epilepsy treatment and method using the same
KR20230163623A (en) electroceuticals design system using AI
KR20240022776A (en) A method of providing a patient-specific customized electronic drug design service
KR20230163173A (en) A method of providing a patient-specific customized electronic drug design service
KR20240023316A (en) Electroceutical monitoring system and server
WO2017095173A1 (en) Earthing test unit
WO2020036439A1 (en) Wearable accessory and circuit protection module provided therein
KR20230155162A (en) Electronic drug monitoring system and server for epilepsy treatment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23812013

Country of ref document: EP

Kind code of ref document: A1